{
  "diseases": [
    {
      "id": "LC",
      "name": "Lung Cancer",
      "category": "Cancer",
      "burden_score": 0.95,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "BC",
      "name": "Breast Cancer",
      "category": "Cancer",
      "burden_score": 0.9,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CRC",
      "name": "Colorectal Cancer",
      "category": "Cancer",
      "burden_score": 0.85,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PC",
      "name": "Prostate Cancer",
      "category": "Cancer",
      "burden_score": 0.8,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "LUC",
      "name": "Leukemia",
      "category": "Cancer",
      "burden_score": 0.8,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "IHD",
      "name": "Ischemic Heart Disease",
      "category": "Cardiovascular",
      "burden_score": 0.95,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "STR",
      "name": "Stroke",
      "category": "Cardiovascular",
      "burden_score": 0.9,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "HTN",
      "name": "Hypertension",
      "category": "Cardiovascular",
      "burden_score": 0.85,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "T2D",
      "name": "Type 2 Diabetes",
      "category": "Metabolic",
      "burden_score": 0.9,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "OBS",
      "name": "Obesity",
      "category": "Metabolic",
      "burden_score": 0.85,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "MS",
      "name": "Metabolic Syndrome",
      "category": "Metabolic",
      "burden_score": 0.8,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ALZ",
      "name": "Alzheimer's Disease",
      "category": "Neurodegenerative",
      "burden_score": 0.9,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PD",
      "name": "Parkinson's Disease",
      "category": "Neurodegenerative",
      "burden_score": 0.8,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ALS",
      "name": "Amyotrophic Lateral Sclerosis",
      "category": "Neurodegenerative",
      "burden_score": 0.75,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "HD",
      "name": "Huntington's Disease",
      "category": "Neurodegenerative",
      "burden_score": 0.7,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "RA",
      "name": "Rheumatoid Arthritis",
      "category": "Autoimmune",
      "burden_score": 0.8,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "SLE",
      "name": "Systemic Lupus Erythematosus",
      "category": "Autoimmune",
      "burden_score": 0.75,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "MS_17",
      "name": "Multiple Sclerosis",
      "category": "Autoimmune",
      "burden_score": 0.7,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CD",
      "name": "Crohn's Disease",
      "category": "Autoimmune",
      "burden_score": 0.65,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PSO",
      "name": "Psoriasis",
      "category": "Autoimmune",
      "burden_score": 0.6,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "HIV",
      "name": "HIV/AIDS",
      "category": "Infectious",
      "burden_score": 0.9,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "HEP",
      "name": "Viral Hepatitis",
      "category": "Infectious",
      "burden_score": 0.85,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "TB",
      "name": "Tuberculosis",
      "category": "Infectious",
      "burden_score": 0.8,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "MAL",
      "name": "Malaria",
      "category": "Infectious",
      "burden_score": 0.75,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "COPD",
      "name": "Chronic Obstructive Pulmonary Disease",
      "category": "Respiratory",
      "burden_score": 0.9,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "AST",
      "name": "Asthma",
      "category": "Respiratory",
      "burden_score": 0.8,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PF",
      "name": "Pulmonary Fibrosis",
      "category": "Respiratory",
      "burden_score": 0.75,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CKD",
      "name": "Chronic Kidney Disease",
      "category": "Kidney",
      "burden_score": 0.85,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NS",
      "name": "Nephrotic Syndrome",
      "category": "Kidney",
      "burden_score": 0.7,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CIR",
      "name": "Cirrhosis",
      "category": "Liver",
      "burden_score": 0.85,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "HEP_30",
      "name": "Hepatitis",
      "category": "Liver",
      "burden_score": 0.8,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NAFLD",
      "name": "Non-Alcoholic Fatty Liver Disease",
      "category": "Liver",
      "burden_score": 0.75,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "DEP",
      "name": "Major Depressive Disorder",
      "category": "Mental Health",
      "burden_score": 0.85,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "SCZ",
      "name": "Schizophrenia",
      "category": "Mental Health",
      "burden_score": 0.8,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "BPD",
      "name": "Bipolar Disorder",
      "category": "Mental Health",
      "burden_score": 0.75,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PKU",
      "name": "Phenylketonuria",
      "category": "Rare Disease",
      "burden_score": 0.6,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CF",
      "name": "Cystic Fibrosis",
      "category": "Rare Disease",
      "burden_score": 0.7,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "MPS",
      "name": "Mucopolysaccharidosis",
      "category": "Rare Disease",
      "burden_score": 0.6,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "FOP",
      "name": "Fibrodysplasia Ossificans Progressiva",
      "category": "Rare Disease",
      "burden_score": 0.5,
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NF",
      "name": "Neurofibromatosis",
      "category": "Rare Disease",
      "burden_score": 0.55,
      "sources": [
        "AI-generated"
      ]
    }
  ],
  "proteins": [
    {
      "id": "TP53",
      "uniprot_id": "P04637",
      "symbol": "TP53",
      "name": "Tumor Protein P53",
      "family": "Transcription Factor",
      "pathways": [
        "Cell Cycle Regulation",
        "Apoptosis",
        "DNA Damage Response"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "EGFR",
      "uniprot_id": "P00533",
      "symbol": "EGFR",
      "name": "Epidermal Growth Factor Receptor",
      "family": "Receptor Tyrosine Kinase",
      "pathways": [
        "Cell Proliferation",
        "Cell Survival",
        "Angiogenesis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "KRAS",
      "uniprot_id": "P01116",
      "symbol": "KRAS",
      "name": "KRAS Proto-Oncogene, GTPase",
      "family": "Small GTPase",
      "pathways": [
        "Cell Proliferation",
        "Cell Survival",
        "Angiogenesis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ALK",
      "uniprot_id": "Q9UM73",
      "symbol": "ALK",
      "name": "Anaplastic Lymphoma Receptor Tyrosine Kinase",
      "family": "Receptor Tyrosine Kinase",
      "pathways": [
        "Cell Proliferation",
        "Cell Survival",
        "Angiogenesis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ERCC1",
      "uniprot_id": "P07992",
      "symbol": "ERCC1",
      "name": "ERCC Excision Repair 1, Endonuclease Non-Catalytic Subunit",
      "family": "DNA Repair Enzyme",
      "pathways": [
        "DNA Damage Repair",
        "Nucleotide Excision Repair"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "BRCA1",
      "uniprot_id": "P38398",
      "symbol": "BRCA1",
      "name": "Breast Cancer Type 1 Susceptibility Protein",
      "family": "Transcription Regulator",
      "pathways": [
        "DNA Repair",
        "Cell Cycle Regulation",
        "Transcription"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "BRCA2",
      "uniprot_id": "P51587",
      "symbol": "BRCA2",
      "name": "Breast Cancer Type 2 Susceptibility Protein",
      "family": "Transcription Regulator",
      "pathways": [
        "DNA Repair",
        "Cell Cycle Regulation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "HER2",
      "uniprot_id": "P04626",
      "symbol": "HER2",
      "name": "Receptor Tyrosine-Protein Kinase erbB-2",
      "family": "Receptor",
      "pathways": [
        "Cell Proliferation",
        "Cell Survival",
        "Angiogenesis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ESR1",
      "uniprot_id": "P03372",
      "symbol": "ESR1",
      "name": "Estrogen Receptor",
      "family": "Nuclear Receptor",
      "pathways": [
        "Hormone Signaling",
        "Cell Proliferation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PIK3CA",
      "uniprot_id": "P42336",
      "symbol": "PIK3CA",
      "name": "Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha",
      "family": "Enzyme",
      "pathways": [
        "Cell Proliferation",
        "Cell Survival",
        "Metabolism"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PTEN",
      "uniprot_id": "P60484",
      "symbol": "PTEN",
      "name": "Phosphatase and Tensin Homolog",
      "family": "Phosphatase",
      "pathways": [
        "Cell Proliferation",
        "Cell Survival",
        "Metabolism"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "MYC",
      "uniprot_id": "P01106",
      "symbol": "MYC",
      "name": "Myc Proto-Oncogene Protein",
      "family": "Transcription Regulator",
      "pathways": [
        "Cell Proliferation",
        "Cell Cycle Regulation",
        "Metabolism"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CCND1",
      "uniprot_id": "P24385",
      "symbol": "CCND1",
      "name": "G1/S-Specific Cyclin-D1",
      "family": "Cell Cycle Regulator",
      "pathways": [
        "Cell Cycle Regulation",
        "Cell Proliferation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "APC",
      "uniprot_id": "P25054",
      "symbol": "APC",
      "name": "Adenomatous Polyposis Coli",
      "family": "Tumor Suppressor",
      "pathways": [
        "Wnt Signaling Pathway",
        "Cell Cycle",
        "Cell-Cell Adhesion"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "BRAF",
      "uniprot_id": "P15056",
      "symbol": "BRAF",
      "name": "B-Raf Proto-Oncogene, Serine/Threonine Kinase",
      "family": "Oncogene",
      "pathways": [
        "MAPK Signaling Pathway",
        "Cell Proliferation",
        "Cell Survival"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NRAS",
      "uniprot_id": "P01111",
      "symbol": "NRAS",
      "name": "NRAS Proto-Oncogene, GTPase",
      "family": "Oncogene",
      "pathways": [
        "MAPK Signaling Pathway",
        "PI3K-Akt Signaling Pathway"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "MLH1",
      "uniprot_id": "P40692",
      "symbol": "MLH1",
      "name": "MutL Homolog 1",
      "family": "DNA Mismatch Repair Protein",
      "pathways": [
        "DNA Mismatch Repair",
        "Microsatellite Instability"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "TGFBR2",
      "uniprot_id": "P37173",
      "symbol": "TGFBR2",
      "name": "Transforming Growth Factor Beta Receptor 2",
      "family": "Receptor",
      "pathways": [
        "TGF-Beta Signaling Pathway",
        "Cell Proliferation",
        "Cell Differentiation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "SMAD4",
      "uniprot_id": "Q13485",
      "symbol": "SMAD4",
      "name": "SMAD Family Member 4",
      "family": "Transcription Factor",
      "pathways": [
        "TGF-Beta Signaling Pathway",
        "Cell Proliferation",
        "Cell Differentiation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PSA",
      "uniprot_id": "P07288",
      "symbol": "PSA",
      "name": "Prostate-specific antigen",
      "family": "Enzyme",
      "pathways": [
        "Androgen receptor signaling pathway",
        "Regulation of cell growth"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "AR",
      "uniprot_id": "P10275",
      "symbol": "AR",
      "name": "Androgen receptor",
      "family": "Nuclear receptor",
      "pathways": [
        "Androgen receptor signaling pathway",
        "Regulation of cell growth"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "TMPRSS2",
      "uniprot_id": "O15393",
      "symbol": "TMPRSS2",
      "name": "Transmembrane protease, serine 2",
      "family": "Protease",
      "pathways": [
        "Androgen receptor signaling pathway",
        "Regulation of cell growth"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "AMACR",
      "uniprot_id": "Q9Y5K2",
      "symbol": "AMACR",
      "name": "Alpha-methylacyl-CoA racemase",
      "family": "Enzyme",
      "pathways": [
        "Fatty acid metabolism",
        "Peroxisome function"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "BCR-ABL1",
      "uniprot_id": "P11274",
      "symbol": "BCR-ABL1",
      "name": "Breakpoint cluster region-Abelson murine leukemia viral oncogene homolog 1 fusion protein",
      "family": "Tyrosine kinase",
      "pathways": [
        "Chronic myeloid leukemia",
        "Regulation of actin cytoskeleton"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "FLT3",
      "uniprot_id": "P36888",
      "symbol": "FLT3",
      "name": "Fms-like tyrosine kinase 3",
      "family": "Tyrosine kinase receptor",
      "pathways": [
        "Acute myeloid leukemia",
        "Hematopoietic cell lineage"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NPM1",
      "uniprot_id": "P06748",
      "symbol": "NPM1",
      "name": "Nucleophosmin",
      "family": "Nucleolar phosphoprotein",
      "pathways": [
        "Acute myeloid leukemia",
        "Ribosome biogenesis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "RUNX1",
      "uniprot_id": "Q01196",
      "symbol": "RUNX1",
      "name": "Runt-related transcription factor 1",
      "family": "Transcription factor",
      "pathways": [
        "Acute myeloid leukemia",
        "Hematopoietic cell lineage"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "LDLR",
      "uniprot_id": "P01130",
      "symbol": "LDLR",
      "name": "Low-density lipoprotein receptor",
      "family": "Receptor",
      "pathways": [
        "Cholesterol metabolism",
        "Lipoprotein metabolism"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PCSK9",
      "uniprot_id": "Q8NBP7",
      "symbol": "PCSK9",
      "name": "Proprotein convertase subtilisin/kexin type 9",
      "family": "Enzyme",
      "pathways": [
        "Cholesterol metabolism",
        "Lipoprotein metabolism"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "HMGCR",
      "uniprot_id": "P04035",
      "symbol": "HMGCR",
      "name": "3-hydroxy-3-methylglutaryl-CoA reductase",
      "family": "Enzyme",
      "pathways": [
        "Cholesterol biosynthesis",
        "Lipid metabolism"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "APOE",
      "uniprot_id": "P02649",
      "symbol": "APOE",
      "name": "Apolipoprotein E",
      "family": "Lipoprotein",
      "pathways": [
        "Cholesterol metabolism",
        "Lipoprotein metabolism"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ABCA1",
      "uniprot_id": "O95477",
      "symbol": "ABCA1",
      "name": "ATP-binding cassette sub-family A member 1",
      "family": "Transporter",
      "pathways": [
        "Cholesterol efflux",
        "Reverse cholesterol transport"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "BDNF",
      "uniprot_id": "P23560",
      "symbol": "BDNF",
      "name": "Brain-derived neurotrophic factor",
      "family": "Growth factor",
      "pathways": [
        "Neuronal survival and differentiation",
        "Synaptic plasticity"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "IL-6",
      "uniprot_id": "P05231",
      "symbol": "IL-6",
      "name": "Interleukin-6",
      "family": "Cytokine",
      "pathways": [
        "Inflammatory response",
        "Acute-phase response"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ACE",
      "uniprot_id": "P12821",
      "symbol": "ACE",
      "name": "Angiotensin-converting enzyme",
      "family": "Enzyme",
      "pathways": [
        "Renin-angiotensin system",
        "Blood pressure regulation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "AGTR1",
      "uniprot_id": "P30556",
      "symbol": "AGTR1",
      "name": "Angiotensin II receptor type 1",
      "family": "Receptor",
      "pathways": [
        "Renin-angiotensin system",
        "Blood pressure regulation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NOS3",
      "uniprot_id": "P29474",
      "symbol": "NOS3",
      "name": "Nitric oxide synthase, endothelial",
      "family": "Enzyme",
      "pathways": [
        "Nitric oxide signaling",
        "Vasodilation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ADRB2",
      "uniprot_id": "P07550",
      "symbol": "ADRB2",
      "name": "Beta-2 adrenergic receptor",
      "family": "Receptor",
      "pathways": [
        "Adrenergic signaling",
        "Vasodilation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CYP11B2",
      "uniprot_id": "P19099",
      "symbol": "CYP11B2",
      "name": "Aldosterone synthase",
      "family": "Enzyme",
      "pathways": [
        "Aldosterone biosynthesis",
        "Renin-angiotensin system"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "INSR",
      "uniprot_id": "P06213",
      "symbol": "INSR",
      "name": "Insulin Receptor",
      "family": "Receptor",
      "pathways": [
        "Insulin signaling pathway",
        "Glucose metabolism",
        "Lipid metabolism"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "GLUT4",
      "uniprot_id": "P14672",
      "symbol": "GLUT4",
      "name": "Glucose Transporter Type 4",
      "family": "Transporter",
      "pathways": [
        "Glucose transport",
        "Insulin signaling pathway"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "IRS1",
      "uniprot_id": "P35568",
      "symbol": "IRS1",
      "name": "Insulin Receptor Substrate 1",
      "family": "Signaling Adaptor",
      "pathways": [
        "Insulin signaling pathway",
        "PI3K-Akt signaling",
        "MAPK signaling"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PPARG",
      "uniprot_id": "P37231",
      "symbol": "PPARG",
      "name": "Peroxisome Proliferator-Activated Receptor Gamma",
      "family": "Nuclear Receptor",
      "pathways": [
        "Adipogenesis",
        "Lipid metabolism",
        "Insulin sensitivity"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ADIPOQ",
      "uniprot_id": "Q15848",
      "symbol": "ADIPOQ",
      "name": "Adiponectin",
      "family": "Adipokine",
      "pathways": [
        "Insulin sensitivity",
        "Lipid metabolism",
        "Anti-inflammatory response"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "LEP",
      "uniprot_id": "P41159",
      "symbol": "LEP",
      "name": "Leptin",
      "family": "Cytokine",
      "pathways": [
        "Regulation of appetite and metabolism",
        "Adipocyte signaling"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "LEPR",
      "uniprot_id": "P48357",
      "symbol": "LEPR",
      "name": "Leptin receptor",
      "family": "Receptor",
      "pathways": [
        "Leptin signaling pathway",
        "Regulation of appetite and metabolism"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "POMC",
      "uniprot_id": "P01189",
      "symbol": "POMC",
      "name": "Pro-opiomelanocortin",
      "family": "Prohormone",
      "pathways": [
        "Regulation of appetite",
        "Melanocortin signaling"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "MC4R",
      "uniprot_id": "P32245",
      "symbol": "MC4R",
      "name": "Melanocortin 4 receptor",
      "family": "Receptor",
      "pathways": [
        "Melanocortin signaling",
        "Regulation of appetite and metabolism"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "FTO",
      "uniprot_id": "Q9C0B1",
      "symbol": "FTO",
      "name": "Alpha-ketoglutarate-dependent dioxygenase FTO",
      "family": "Enzyme",
      "pathways": [
        "Regulation of body weight",
        "RNA methylation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "SREBF1",
      "uniprot_id": "P36956",
      "symbol": "SREBF1",
      "name": "Sterol regulatory element-binding protein 1",
      "family": "Transcription factor",
      "pathways": [
        "Lipid biosynthesis",
        "Glucose metabolism"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "APP",
      "uniprot_id": "P05067",
      "symbol": "APP",
      "name": "Amyloid Precursor Protein",
      "family": "Transmembrane Protein",
      "pathways": [
        "Amyloid Processing",
        "Synaptic Function",
        "Neurodegeneration"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PSEN1",
      "uniprot_id": "P49768",
      "symbol": "PSEN1",
      "name": "Presenilin-1",
      "family": "Enzyme",
      "pathways": [
        "Amyloid Processing",
        "Notch Signaling",
        "Neurodegeneration"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "MAPT",
      "uniprot_id": "P10636",
      "symbol": "MAPT",
      "name": "Microtubule-Associated Protein Tau",
      "family": "Cytoskeletal Protein",
      "pathways": [
        "Microtubule Dynamics",
        "Neurodegeneration",
        "Synaptic Function"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "BACE1",
      "uniprot_id": "P56817",
      "symbol": "BACE1",
      "name": "Beta-Secretase 1",
      "family": "Enzyme",
      "pathways": [
        "Amyloid Processing",
        "Neurodegeneration"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "SNCA",
      "uniprot_id": "P37840",
      "symbol": "SNCA",
      "name": "Alpha-synuclein",
      "family": "Protein",
      "pathways": [
        "Parkinson's disease",
        "Neurodegenerative diseases"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "LRRK2",
      "uniprot_id": "Q5S007",
      "symbol": "LRRK2",
      "name": "Leucine-rich repeat serine/threonine-protein kinase 2",
      "family": "Kinase",
      "pathways": [
        "Parkinson's disease",
        "Neurodegeneration"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "GBA",
      "uniprot_id": "P04062",
      "symbol": "GBA",
      "name": "Glucosylceramidase",
      "family": "Enzyme",
      "pathways": [
        "Parkinson's disease",
        "Lysosomal storage disorders"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PARK7",
      "uniprot_id": "Q99497",
      "symbol": "PARK7",
      "name": "Protein DJ-1",
      "family": "Protein",
      "pathways": [
        "Parkinson's disease",
        "Oxidative stress response"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PINK1",
      "uniprot_id": "Q9BXM7",
      "symbol": "PINK1",
      "name": "Serine/threonine-protein kinase PINK1, mitochondrial",
      "family": "Kinase",
      "pathways": [
        "Parkinson's disease",
        "Mitochondrial function"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "UCHL1",
      "uniprot_id": "P09936",
      "symbol": "UCHL1",
      "name": "Ubiquitin carboxyl-terminal hydrolase isozyme L1",
      "family": "Enzyme",
      "pathways": [
        "Parkinson's disease",
        "Ubiquitin-proteasome system"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NURR1",
      "uniprot_id": "Q13133",
      "symbol": "NURR1",
      "name": "Nuclear receptor subfamily 4 group A member 1",
      "family": "Transcription factor",
      "pathways": [
        "Parkinson's disease",
        "Dopaminergic neuron development"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "VMAT2",
      "uniprot_id": "Q05940",
      "symbol": "VMAT2",
      "name": "Synaptic vesicular amine transporter",
      "family": "Transporter",
      "pathways": [
        "Parkinson's disease",
        "Neurotransmitter transport"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "SOD1",
      "uniprot_id": "P00441",
      "symbol": "SOD1",
      "name": "Superoxide dismutase [Cu-Zn]",
      "family": "Enzyme",
      "pathways": [
        "Oxidative stress response",
        "Superoxide metabolic process"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "TARDBP",
      "uniprot_id": "Q13148",
      "symbol": "TARDBP",
      "name": "TAR DNA-binding protein 43",
      "family": "RNA-binding protein",
      "pathways": [
        "RNA processing",
        "Transcription regulation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "FUS",
      "uniprot_id": "P35637",
      "symbol": "FUS",
      "name": "RNA-binding protein FUS",
      "family": "RNA-binding protein",
      "pathways": [
        "RNA processing",
        "Transcription regulation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "C9orf72",
      "uniprot_id": "Q96LT7",
      "symbol": "C9ORF72",
      "name": "Chromosome 9 open reading frame 72",
      "family": "Guanine nucleotide exchange factor",
      "pathways": [
        "Endosomal transport",
        "Autophagy"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NEFL",
      "uniprot_id": "P07196",
      "symbol": "NEFL",
      "name": "Neurofilament light polypeptide",
      "family": "Structural protein",
      "pathways": [
        "Cytoskeleton organization",
        "Axon guidance"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "HTT",
      "uniprot_id": "P42858",
      "symbol": "HTT",
      "name": "Huntingtin",
      "family": "Protein",
      "pathways": [
        "Huntington's disease",
        "Neurodegenerative diseases"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CREB1",
      "uniprot_id": "P16220",
      "symbol": "CREB1",
      "name": "cAMP Response Element-Binding Protein 1",
      "family": "Transcription factor",
      "pathways": [
        "CREB signaling in neurons",
        "Huntington's disease"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CASP3",
      "uniprot_id": "P42574",
      "symbol": "CASP3",
      "name": "Caspase-3",
      "family": "Protease",
      "pathways": [
        "Apoptosis",
        "Huntington's disease"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "GRIN2B",
      "uniprot_id": "Q13224",
      "symbol": "GRIN2B",
      "name": "Glutamate Ionotropic Receptor NMDA Type Subunit 2B",
      "family": "Receptor",
      "pathways": [
        "Glutamatergic synapse",
        "Huntington's disease"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NR4A2",
      "uniprot_id": "P43354",
      "symbol": "NR4A2",
      "name": "Nuclear Receptor Subfamily 4 Group A Member 2",
      "family": "Transcription factor",
      "pathways": [
        "Huntington's disease",
        "Parkinson's disease"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "TNF",
      "uniprot_id": "P01375",
      "symbol": "TNF",
      "name": "Tumor Necrosis Factor",
      "family": "Cytokine",
      "pathways": [
        "Inflammatory response",
        "Apoptosis",
        "NF-kappa B signaling pathway"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CTLA4",
      "uniprot_id": "P16410",
      "symbol": "CTLA4",
      "name": "Cytotoxic T-Lymphocyte Associated Protein 4",
      "family": "Receptor",
      "pathways": [
        "T cell costimulation",
        "Immune regulation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PTPN22",
      "uniprot_id": "Q9Y2R2",
      "symbol": "PTPN22",
      "name": "Protein Tyrosine Phosphatase Non-Receptor Type 22",
      "family": "Enzyme",
      "pathways": [
        "T cell receptor signaling",
        "Immune regulation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "HLA-DRB1",
      "uniprot_id": "P01912",
      "symbol": "HLA-DRB1",
      "name": "Major Histocompatibility Complex, Class II, DR Beta 1",
      "family": "Receptor",
      "pathways": [
        "Antigen presentation",
        "T cell activation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "IFNG",
      "uniprot_id": "P01579",
      "symbol": "IFNG",
      "name": "Interferon gamma",
      "family": "Cytokine",
      "pathways": [
        "Immune system",
        "Inflammatory response",
        "Autoimmunity"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "STAT1",
      "uniprot_id": "P42224",
      "symbol": "STAT1",
      "name": "Signal transducer and activator of transcription 1",
      "family": "Transcription factor",
      "pathways": [
        "Immune system",
        "Interferon signaling",
        "Autoimmunity"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "BAFF",
      "uniprot_id": "Q9Y275",
      "symbol": "BAFF",
      "name": "B-cell activating factor",
      "family": "Cytokine",
      "pathways": [
        "Immune system",
        "B cell activation",
        "Autoimmunity"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "IL-17A",
      "uniprot_id": "Q16552",
      "symbol": "IL-17A",
      "name": "Interleukin-17A",
      "family": "Cytokine",
      "pathways": [
        "Immune system",
        "Cytokine signaling in immune system"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "MBP",
      "uniprot_id": "P02686",
      "symbol": "MBP",
      "name": "Myelin basic protein",
      "family": "Structural protein",
      "pathways": [
        "Myelin formation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "MOG",
      "uniprot_id": "Q16653",
      "symbol": "MOG",
      "name": "Myelin oligodendrocyte glycoprotein",
      "family": "Cell surface receptor",
      "pathways": [
        "Myelin formation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CXCL12",
      "uniprot_id": "P48061",
      "symbol": "CXCL12",
      "name": "C-X-C motif chemokine 12",
      "family": "Chemokine",
      "pathways": [
        "Immune system",
        "Cytokine signaling in immune system"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "HLA-DRB1_P01911",
      "uniprot_id": "P01911",
      "symbol": "HLA-DRB1",
      "name": "HLA class II histocompatibility antigen, DRB1 beta chain",
      "family": "MHC class II receptor",
      "pathways": [
        "Antigen processing and presentation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "TGFB1",
      "uniprot_id": "P01137",
      "symbol": "TGFB1",
      "name": "Transforming growth factor beta-1",
      "family": "Growth factor",
      "pathways": [
        "Immune system",
        "Cytokine signaling in immune system"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NOS2",
      "uniprot_id": "P35228",
      "symbol": "NOS2",
      "name": "Nitric oxide synthase, inducible",
      "family": "Oxidoreductase",
      "pathways": [
        "Nitric oxide signaling",
        "Immune system"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PTPRC",
      "uniprot_id": "P08575",
      "symbol": "PTPRC",
      "name": "Receptor-type tyrosine-protein phosphatase C",
      "family": "Protein tyrosine phosphatase",
      "pathways": [
        "Immune system",
        "T cell receptor signaling"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "STAT3",
      "uniprot_id": "P40763",
      "symbol": "STAT3",
      "name": "Signal Transducer and Activator of Transcription 3",
      "family": "Transcription factor",
      "pathways": [
        "JAK-STAT signaling",
        "Cell proliferation",
        "Inflammatory response"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NOD2",
      "uniprot_id": "Q9Y2X3",
      "symbol": "NOD2",
      "name": "Nucleotide-Binding Oligomerization Domain-Containing Protein 2",
      "family": "Pattern recognition receptor",
      "pathways": [
        "Innate immune response",
        "NF-kappa B signaling",
        "Autophagy"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "IL-23",
      "uniprot_id": "Q9NPF7",
      "symbol": "IL-23",
      "name": "Interleukin-23",
      "family": "Cytokine",
      "pathways": [
        "Inflammatory response",
        "Immune system activation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "VEGF",
      "uniprot_id": "P15692",
      "symbol": "VEGF",
      "name": "Vascular Endothelial Growth Factor",
      "family": "Growth factor",
      "pathways": [
        "Angiogenesis",
        "Vascular permeability"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "HIV-1 Gag",
      "uniprot_id": "P04585",
      "symbol": "HIV-1 GAG",
      "name": "HIV-1 Gag polyprotein",
      "family": "Viral protein",
      "pathways": [
        "Viral life cycle",
        "Viral assembly and release"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "HIV-1 Env",
      "uniprot_id": "P04578",
      "symbol": "HIV-1 ENV",
      "name": "HIV-1 envelope glycoprotein",
      "family": "Viral protein",
      "pathways": [
        "Viral entry",
        "Host-virus interaction"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "HIV-1 Rev",
      "uniprot_id": "P04618",
      "symbol": "HIV-1 REV",
      "name": "HIV-1 Rev protein",
      "family": "Viral protein",
      "pathways": [
        "Viral gene expression",
        "RNA transport"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "HIV-1 Tat",
      "uniprot_id": "P04608",
      "symbol": "HIV-1 TAT",
      "name": "HIV-1 Tat protein",
      "family": "Viral protein",
      "pathways": [
        "Viral gene expression",
        "Transcriptional regulation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CD4",
      "uniprot_id": "P01730",
      "symbol": "CD4",
      "name": "T-cell surface glycoprotein CD4",
      "family": "Receptor",
      "pathways": [
        "T cell activation",
        "Host-virus interaction"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NTCP",
      "uniprot_id": "Q06218",
      "symbol": "NTCP",
      "name": "Sodium/Taurocholate Cotransporting Polypeptide",
      "family": "Transporter",
      "pathways": [
        "Bile acid transport",
        "Viral entry into host cell"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CLDN1",
      "uniprot_id": "O95832",
      "symbol": "CLDN1",
      "name": "Claudin-1",
      "family": "Tight Junction Protein",
      "pathways": [
        "Cell-cell adhesion",
        "Viral entry into host cell"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ESAT-6",
      "uniprot_id": "P0A556",
      "symbol": "ESAT-6",
      "name": "6 kDa early secretory antigenic target",
      "family": "Virulence factor",
      "pathways": [
        "Mycobacterium tuberculosis infection",
        "Phagosome"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CFP-10",
      "uniprot_id": "P0A5B2",
      "symbol": "CFP-10",
      "name": "Culture filtrate protein 10",
      "family": "Virulence factor",
      "pathways": [
        "Mycobacterium tuberculosis infection",
        "Phagosome"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "Rv3875",
      "uniprot_id": "O06185",
      "symbol": "RV3875",
      "name": "ESAT-6-like protein EsxA",
      "family": "Virulence factor",
      "pathways": [
        "Mycobacterium tuberculosis infection",
        "Phagosome"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "Rv3874",
      "uniprot_id": "O06184",
      "symbol": "RV3874",
      "name": "ESAT-6-like protein EsxB",
      "family": "Virulence factor",
      "pathways": [
        "Mycobacterium tuberculosis infection",
        "Phagosome"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "Rv1886c",
      "uniprot_id": "P31952",
      "symbol": "RV1886C",
      "name": "Antigen 85-B",
      "family": "Enzyme",
      "pathways": [
        "Mycobacterium tuberculosis infection",
        "Mycobacterial cell wall biosynthesis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PfHRP2",
      "uniprot_id": "Q8I1Z5",
      "symbol": "PFHRP2",
      "name": "Plasmodium falciparum Histidine-Rich Protein 2",
      "family": "Enzyme",
      "pathways": [
        "Malaria",
        "Pathogenesis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PfHRP3",
      "uniprot_id": "Q8I1Z4",
      "symbol": "PFHRP3",
      "name": "Plasmodium falciparum Histidine-Rich Protein 3",
      "family": "Enzyme",
      "pathways": [
        "Malaria",
        "Pathogenesis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PfAMA1",
      "uniprot_id": "Q06478",
      "symbol": "PFAMA1",
      "name": "Plasmodium falciparum Apical Membrane Antigen 1",
      "family": "Receptor",
      "pathways": [
        "Malaria",
        "Host-Pathogen Interaction",
        "Invasion"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PfMSP1",
      "uniprot_id": "P12478",
      "symbol": "PFMSP1",
      "name": "Plasmodium falciparum Merozoite Surface Protein 1",
      "family": "Receptor",
      "pathways": [
        "Malaria",
        "Host-Pathogen Interaction",
        "Invasion"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PfEMP1",
      "uniprot_id": "Q9TY95",
      "symbol": "PFEMP1",
      "name": "Plasmodium falciparum Erythrocyte Membrane Protein 1",
      "family": "Receptor",
      "pathways": [
        "Malaria",
        "Pathogenesis",
        "Cytoadhesion"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "MMP9",
      "uniprot_id": "P14780",
      "symbol": "MMP9",
      "name": "Matrix Metalloproteinase-9",
      "family": "Enzyme",
      "pathways": [
        "Extracellular matrix degradation",
        "Tissue remodeling",
        "Inflammation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "IL4",
      "uniprot_id": "P05112",
      "symbol": "IL4",
      "name": "Interleukin-4",
      "family": "Cytokine",
      "pathways": [
        "Cytokine signaling in immune system",
        "Immune system"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "IL5",
      "uniprot_id": "P05113",
      "symbol": "IL5",
      "name": "Interleukin-5",
      "family": "Cytokine",
      "pathways": [
        "Cytokine signaling in immune system",
        "Immune system"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "IL13",
      "uniprot_id": "P35225",
      "symbol": "IL13",
      "name": "Interleukin-13",
      "family": "Cytokine",
      "pathways": [
        "Cytokine signaling in immune system",
        "Immune system"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "TSLP",
      "uniprot_id": "Q969D9",
      "symbol": "TSLP",
      "name": "Thymic stromal lymphopoietin",
      "family": "Cytokine",
      "pathways": [
        "Cytokine signaling in immune system",
        "Immune system"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CTGF",
      "uniprot_id": "P29279",
      "symbol": "CTGF",
      "name": "Connective Tissue Growth Factor",
      "family": "Cytokine",
      "pathways": [
        "Regulation of cell growth",
        "Extracellular matrix organization",
        "Fibroblast proliferation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "MMP-7",
      "uniprot_id": "P09237",
      "symbol": "MMP-7",
      "name": "Matrix Metallopeptidase 7",
      "family": "Enzyme",
      "pathways": [
        "Extracellular matrix degradation",
        "Epithelial-mesenchymal transition"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PDGF-BB",
      "uniprot_id": "P01127",
      "symbol": "PDGF-BB",
      "name": "Platelet Derived Growth Factor Subunit B",
      "family": "Cytokine",
      "pathways": [
        "Regulation of cell growth",
        "Fibroblast proliferation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CCL2",
      "uniprot_id": "P13500",
      "symbol": "CCL2",
      "name": "C-C Motif Chemokine Ligand 2",
      "family": "Cytokine",
      "pathways": [
        "Inflammatory response",
        "Leukocyte migration"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "SP-A",
      "uniprot_id": "P35247",
      "symbol": "SP-A",
      "name": "Surfactant Protein A",
      "family": "Protein",
      "pathways": [
        "Immune response",
        "Surfactant homeostasis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "KL-6",
      "uniprot_id": "P02538",
      "symbol": "KL-6",
      "name": "Keratin 6",
      "family": "Protein",
      "pathways": [
        "Cell adhesion",
        "Epithelial cell differentiation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NPHS1",
      "uniprot_id": "O60500",
      "symbol": "NPHS1",
      "name": "Nephrin",
      "family": "Structural protein",
      "pathways": [
        "Glomerular filtration",
        "Podocyte function"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NGAL",
      "uniprot_id": "P80188",
      "symbol": "NGAL",
      "name": "Neutrophil gelatinase-associated lipocalin",
      "family": "Biomarker",
      "pathways": [
        "Acute kidney injury",
        "Inflammation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NPHS2",
      "uniprot_id": "Q9NP85",
      "symbol": "NPHS2",
      "name": "Podocin",
      "family": "Transmembrane protein",
      "pathways": [
        "Podocyte slit diaphragm formation",
        "Regulation of actin cytoskeleton"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ACTN4",
      "uniprot_id": "O43707",
      "symbol": "ACTN4",
      "name": "Alpha-actinin-4",
      "family": "Actin-binding protein",
      "pathways": [
        "Regulation of actin cytoskeleton",
        "Cell adhesion"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "WT1",
      "uniprot_id": "P19544",
      "symbol": "WT1",
      "name": "Wilms Tumor 1",
      "family": "Transcription factor",
      "pathways": [
        "Podocyte development",
        "Regulation of gene expression"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "TRPC6",
      "uniprot_id": "Q9Y210",
      "symbol": "TRPC6",
      "name": "Transient receptor potential cation channel subfamily C member 6",
      "family": "Ion channel",
      "pathways": [
        "Calcium signaling",
        "Regulation of actin cytoskeleton"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ACTA2",
      "uniprot_id": "P62736",
      "symbol": "ACTA2",
      "name": "Actin, alpha 2, smooth muscle, aorta",
      "family": "Cytoskeletal Protein",
      "pathways": [
        "Regulation of actin cytoskeleton",
        "Smooth muscle contraction"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "TIMP1",
      "uniprot_id": "P01033",
      "symbol": "TIMP1",
      "name": "TIMP metallopeptidase inhibitor 1",
      "family": "Protease Inhibitor",
      "pathways": [
        "Extracellular matrix organization",
        "Regulation of metalloprotease activity"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "COL1A1",
      "uniprot_id": "P02452",
      "symbol": "COL1A1",
      "name": "Collagen type I alpha 1 chain",
      "family": "Extracellular Matrix Protein",
      "pathways": [
        "Collagen formation",
        "Extracellular matrix organization"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PDGFRB",
      "uniprot_id": "P09619",
      "symbol": "PDGFRB",
      "name": "Platelet-derived growth factor receptor beta",
      "family": "Receptor Tyrosine Kinase",
      "pathways": [
        "PDGF signaling pathway",
        "Regulation of cell proliferation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PNPLA3",
      "uniprot_id": "Q9NP71",
      "symbol": "PNPLA3",
      "name": "Patatin-like phospholipase domain-containing protein 3",
      "family": "Enzyme",
      "pathways": [
        "Lipid metabolism",
        "Triglyceride homeostasis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "FGF21",
      "uniprot_id": "Q9NSA1",
      "symbol": "FGF21",
      "name": "Fibroblast growth factor 21",
      "family": "Growth factor",
      "pathways": [
        "Lipid metabolism",
        "Glucose homeostasis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "5-HTT",
      "uniprot_id": "P31645",
      "symbol": "5-HTT",
      "name": "Serotonin Transporter",
      "family": "Neurotransmitter Transporter",
      "pathways": [
        "Serotonin neurotransmitter release cycle",
        "Regulation of mood and behavior"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "FKBP5",
      "uniprot_id": "Q13451",
      "symbol": "FKBP5",
      "name": "FK506 Binding Protein 5",
      "family": "Immunophilin",
      "pathways": [
        "Glucocorticoid receptor signaling",
        "Regulation of stress response"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "DISC1",
      "uniprot_id": "Q9NRI5",
      "symbol": "DISC1",
      "name": "Disrupted in schizophrenia 1",
      "family": "Scaffold protein",
      "pathways": [
        "Neuronal development",
        "Synaptic function",
        "Mitochondrial dynamics"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "DTNBP1",
      "uniprot_id": "Q96EV8",
      "symbol": "DTNBP1",
      "name": "Dystrobrevin-binding protein 1",
      "family": "Synaptic protein",
      "pathways": [
        "Synaptic vesicle trafficking",
        "Glutamate receptor signaling"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NRG1",
      "uniprot_id": "Q02297",
      "symbol": "NRG1",
      "name": "Neuregulin 1",
      "family": "Growth factor",
      "pathways": [
        "Neurodevelopment",
        "Synaptic plasticity",
        "Myelination"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "GRIN2A",
      "uniprot_id": "Q12879",
      "symbol": "GRIN2A",
      "name": "Glutamate ionotropic receptor NMDA type subunit 2A",
      "family": "Neurotransmitter receptor",
      "pathways": [
        "Glutamate signaling",
        "Synaptic transmission",
        "Neuroplasticity"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "GSK3B",
      "uniprot_id": "P49841",
      "symbol": "GSK3B",
      "name": "Glycogen Synthase Kinase 3 Beta",
      "family": "Kinase",
      "pathways": [
        "Wnt signaling pathway",
        "Insulin signaling pathway"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "COMT",
      "uniprot_id": "P21964",
      "symbol": "COMT",
      "name": "Catechol-O-Methyltransferase",
      "family": "Enzyme",
      "pathways": [
        "Dopamine metabolism",
        "Catecholamine biosynthesis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CACNA1C",
      "uniprot_id": "Q13936",
      "symbol": "CACNA1C",
      "name": "Calcium Voltage-Gated Channel Subunit Alpha1 C",
      "family": "Ion Channel",
      "pathways": [
        "Calcium signaling pathway",
        "Neuronal excitability"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PAH",
      "uniprot_id": "P00439",
      "symbol": "PAH",
      "name": "Phenylalanine hydroxylase",
      "family": "Enzyme",
      "pathways": [
        "Phenylalanine metabolism",
        "Amino acid metabolism"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "QDPR",
      "uniprot_id": "P09417",
      "symbol": "QDPR",
      "name": "Quinoid dihydropteridine reductase",
      "family": "Enzyme",
      "pathways": [
        "Tetrahydrobiopterin biosynthesis",
        "Cofactor metabolism"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "PTS",
      "uniprot_id": "P11327",
      "symbol": "PTS",
      "name": "6-pyruvoyltetrahydropterin synthase",
      "family": "Enzyme",
      "pathways": [
        "Tetrahydrobiopterin biosynthesis",
        "Cofactor metabolism"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CFTR",
      "uniprot_id": "P13569",
      "symbol": "CFTR",
      "name": "Cystic Fibrosis Transmembrane Conductance Regulator",
      "family": "Ion Channel",
      "pathways": [
        "Chloride Ion Transport",
        "Epithelial Ion Transport"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ENaC",
      "uniprot_id": "P37088",
      "symbol": "ENAC",
      "name": "Epithelial Sodium Channel",
      "family": "Ion Channel",
      "pathways": [
        "Sodium Ion Transport",
        "Epithelial Ion Transport"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "SERPINA1",
      "uniprot_id": "P01009",
      "symbol": "SERPINA1",
      "name": "Alpha-1-Antitrypsin",
      "family": "Serine Protease Inhibitor",
      "pathways": [
        "Protease-Antiprotease Balance",
        "Lung Function Regulation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "IL8",
      "uniprot_id": "P10145",
      "symbol": "IL8",
      "name": "Interleukin-8",
      "family": "Chemokine",
      "pathways": [
        "Inflammatory Response",
        "Neutrophil Recruitment"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NE",
      "uniprot_id": "P08246",
      "symbol": "NE",
      "name": "Neutrophil Elastase",
      "family": "Serine Protease",
      "pathways": [
        "Protease-Antiprotease Balance",
        "Lung Tissue Damage"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "IDUA",
      "uniprot_id": "P35475",
      "symbol": "IDUA",
      "name": "Alpha-L-iduronidase",
      "family": "Enzyme",
      "pathways": [
        "Glycosaminoglycan degradation",
        "Lysosome"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "IDS",
      "uniprot_id": "P22304",
      "symbol": "IDS",
      "name": "Iduronate 2-sulfatase",
      "family": "Enzyme",
      "pathways": [
        "Glycosaminoglycan degradation",
        "Lysosome"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "GALNS",
      "uniprot_id": "P34059",
      "symbol": "GALNS",
      "name": "N-acetylgalactosamine-6-sulfatase",
      "family": "Enzyme",
      "pathways": [
        "Glycosaminoglycan degradation",
        "Lysosome"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ARSB",
      "uniprot_id": "P15848",
      "symbol": "ARSB",
      "name": "Arylsulfatase B",
      "family": "Enzyme",
      "pathways": [
        "Glycosaminoglycan degradation",
        "Lysosome"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NAGLU",
      "uniprot_id": "P54802",
      "symbol": "NAGLU",
      "name": "Alpha-N-acetylglucosaminidase",
      "family": "Enzyme",
      "pathways": [
        "Glycosaminoglycan degradation",
        "Lysosome"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ACVR1",
      "uniprot_id": "Q04771",
      "symbol": "ACVR1",
      "name": "Activin receptor type-1",
      "family": "Receptor",
      "pathways": [
        "Bone morphogenetic protein (BMP) signaling pathway",
        "Regulation of bone mineralization"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "BMP4",
      "uniprot_id": "P12644",
      "symbol": "BMP4",
      "name": "Bone morphogenetic protein 4",
      "family": "Growth factor",
      "pathways": [
        "Bone morphogenetic protein (BMP) signaling pathway",
        "Regulation of bone mineralization"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "SMAD1",
      "uniprot_id": "Q15797",
      "symbol": "SMAD1",
      "name": "Mothers against decapentaplegic homolog 1",
      "family": "Transcription factor",
      "pathways": [
        "Bone morphogenetic protein (BMP) signaling pathway",
        "Regulation of bone mineralization"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "GREM1",
      "uniprot_id": "Q92908",
      "symbol": "GREM1",
      "name": "Gremlin-1",
      "family": "Antagonist",
      "pathways": [
        "Bone morphogenetic protein (BMP) signaling pathway",
        "Regulation of bone mineralization"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ENPP1",
      "uniprot_id": "P22413",
      "symbol": "ENPP1",
      "name": "Ectonucleotide pyrophosphatase/phosphodiesterase family member 1",
      "family": "Enzyme",
      "pathways": [
        "Regulation of bone mineralization"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "NF1",
      "uniprot_id": "Q16287",
      "symbol": "NF1",
      "name": "Neurofibromin",
      "family": "Enzyme",
      "pathways": [
        "Ras Signaling",
        "MAPK Signaling",
        "Cell Growth and Proliferation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "MEK1/2",
      "uniprot_id": "Q02750, P36507",
      "symbol": "MEK1/2",
      "name": "Mitogen-activated protein kinase kinase 1/2",
      "family": "Enzyme",
      "pathways": [
        "Ras Signaling",
        "MAPK Signaling",
        "Cell Growth and Proliferation"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "CDKN2A",
      "uniprot_id": "P42771",
      "symbol": "CDKN2A",
      "name": "Cyclin-dependent kinase inhibitor 2A",
      "family": "Enzyme Inhibitor",
      "pathways": [
        "Cell Cycle Regulation",
        "Tumor Suppressor Signaling"
      ],
      "sources": [
        "AI-generated"
      ]
    }
  ],
  "associations": [
    {
      "id": "LC-TP53",
      "disease_id": "LC",
      "protein_id": "TP53",
      "association_strength": 0.8,
      "evidence_text": "TP53 is a well-established tumor suppressor gene that is frequently mutated in lung cancer, contributing to disease development and progression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:06.823392"
    },
    {
      "id": "LC-EGFR",
      "disease_id": "LC",
      "protein_id": "EGFR",
      "association_strength": 0.7,
      "evidence_text": "EGFR mutations are common in lung adenocarcinoma and are associated with sensitivity to EGFR tyrosine kinase inhibitor therapies.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:06.823431"
    },
    {
      "id": "LC-KRAS",
      "disease_id": "LC",
      "protein_id": "KRAS",
      "association_strength": 0.6,
      "evidence_text": "KRAS mutations are also frequently observed in lung adenocarcinoma and are associated with poorer prognosis and resistance to certain targeted therapies.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:06.823433"
    },
    {
      "id": "LC-ALK",
      "disease_id": "LC",
      "protein_id": "ALK",
      "association_strength": 0.5,
      "evidence_text": "ALK rearrangements are found in a subset of lung adenocarcinomas and are targetable by ALK inhibitor drugs.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:06.823434"
    },
    {
      "id": "LC-ERCC1",
      "disease_id": "LC",
      "protein_id": "ERCC1",
      "association_strength": 0.4,
      "evidence_text": "ERCC1 expression has been associated with resistance to platinum-based chemotherapy in lung cancer, though its role is still under investigation.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:36:06.823436"
    },
    {
      "id": "LC-BRCA1",
      "disease_id": "LC",
      "protein_id": "BRCA1",
      "association_strength": 0.3,
      "evidence_text": "BRCA1 mutations have been linked to a small subset of lung cancers, particularly in individuals with a family history of the disease.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:36:06.823437"
    },
    {
      "id": "LC-BRCA2",
      "disease_id": "LC",
      "protein_id": "BRCA2",
      "association_strength": 0.3,
      "evidence_text": "BRCA2 mutations have also been reported in lung cancer, though less frequently than BRCA1, and may confer increased sensitivity to certain therapies.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:36:06.823438"
    },
    {
      "id": "BC-TP53",
      "disease_id": "BC",
      "protein_id": "TP53",
      "association_strength": 0.8,
      "evidence_text": "TP53 is a well-established tumor suppressor gene that is frequently mutated in breast cancer, contributing to disease development and progression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:12.673910"
    },
    {
      "id": "BC-BRCA1",
      "disease_id": "BC",
      "protein_id": "BRCA1",
      "association_strength": 0.7,
      "evidence_text": "BRCA1 and BRCA2 are known breast cancer susceptibility genes, and germline mutations in these genes are associated with increased risk of developing breast cancer.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:12.673932"
    },
    {
      "id": "BC-BRCA2",
      "disease_id": "BC",
      "protein_id": "BRCA2",
      "association_strength": 0.7,
      "evidence_text": "BRCA1 and BRCA2 are known breast cancer susceptibility genes, and germline mutations in these genes are associated with increased risk of developing breast cancer.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:12.673935"
    },
    {
      "id": "BC-HER2",
      "disease_id": "BC",
      "protein_id": "HER2",
      "association_strength": 0.6,
      "evidence_text": "HER2 (ERBB2) is a well-known oncogene that is amplified or overexpressed in a subset of breast cancers, leading to more aggressive disease and poorer prognosis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:12.673938"
    },
    {
      "id": "BC-ESR1",
      "disease_id": "BC",
      "protein_id": "ESR1",
      "association_strength": 0.5,
      "evidence_text": "ESR1 (estrogen receptor alpha) is a key driver of hormone-dependent breast cancers, and its expression status is a critical biomarker for treatment selection.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:12.673941"
    },
    {
      "id": "BC-PIK3CA",
      "disease_id": "BC",
      "protein_id": "PIK3CA",
      "association_strength": 0.4,
      "evidence_text": "PIK3CA is frequently mutated in breast cancer, leading to activation of the PI3K/AKT signaling pathway and contributing to tumor growth and survival.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:12.673943"
    },
    {
      "id": "BC-PTEN",
      "disease_id": "BC",
      "protein_id": "PTEN",
      "association_strength": 0.4,
      "evidence_text": "PTEN is a tumor suppressor gene that is often inactivated in breast cancer, leading to dysregulation of the PI3K/AKT pathway and promoting tumor progression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:12.673949"
    },
    {
      "id": "BC-MYC",
      "disease_id": "BC",
      "protein_id": "MYC",
      "association_strength": 0.4,
      "evidence_text": "MYC is a proto-oncogene that is frequently amplified or overexpressed in breast cancer, contributing to uncontrolled cell proliferation and tumor growth.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:12.673951"
    },
    {
      "id": "BC-CCND1",
      "disease_id": "BC",
      "protein_id": "CCND1",
      "association_strength": 0.4,
      "evidence_text": "CCND1 (cyclin D1) is a cell cycle regulator that is often amplified or overexpressed in breast cancer, leading to dysregulation of cell cycle control and tumor progression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:12.673953"
    },
    {
      "id": "CRC-TP53",
      "disease_id": "CRC",
      "protein_id": "TP53",
      "association_strength": 0.8,
      "evidence_text": "TP53 is a well-established tumor suppressor gene that is frequently mutated in colorectal cancer, contributing to disease development and progression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:17.957824"
    },
    {
      "id": "CRC-KRAS",
      "disease_id": "CRC",
      "protein_id": "KRAS",
      "association_strength": 0.7,
      "evidence_text": "KRAS mutations are found in a significant proportion of colorectal cancers and are associated with resistance to certain targeted therapies.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:17.957876"
    },
    {
      "id": "CRC-APC",
      "disease_id": "CRC",
      "protein_id": "APC",
      "association_strength": 0.7,
      "evidence_text": "APC is a key regulator of the Wnt signaling pathway, and its inactivation is an early and critical event in the development of most colorectal cancers.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:17.957879"
    },
    {
      "id": "CRC-BRAF",
      "disease_id": "CRC",
      "protein_id": "BRAF",
      "association_strength": 0.6,
      "evidence_text": "BRAF mutations, particularly the V600E mutation, are found in a subset of colorectal cancers and are associated with a more aggressive disease course.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:17.957881"
    },
    {
      "id": "CRC-PIK3CA",
      "disease_id": "CRC",
      "protein_id": "PIK3CA",
      "association_strength": 0.5,
      "evidence_text": "PIK3CA mutations are found in a significant proportion of colorectal cancers and are associated with increased cell proliferation and survival.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:17.957883"
    },
    {
      "id": "CRC-PTEN",
      "disease_id": "CRC",
      "protein_id": "PTEN",
      "association_strength": 0.4,
      "evidence_text": "PTEN is a tumor suppressor gene that is frequently inactivated in colorectal cancer, leading to dysregulation of the PI3K/Akt signaling pathway.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:17.957884"
    },
    {
      "id": "CRC-MYC",
      "disease_id": "CRC",
      "protein_id": "MYC",
      "association_strength": 0.4,
      "evidence_text": "MYC is a proto-oncogene that is often overexpressed in colorectal cancer, contributing to increased cell proliferation and survival.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:17.957886"
    },
    {
      "id": "CRC-CCND1",
      "disease_id": "CRC",
      "protein_id": "CCND1",
      "association_strength": 0.4,
      "evidence_text": "CCND1 (cyclin D1) is a cell cycle regulator that is frequently overexpressed in colorectal cancer, leading to uncontrolled cell division.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:17.957887"
    },
    {
      "id": "PC-TP53",
      "disease_id": "PC",
      "protein_id": "TP53",
      "association_strength": 0.7,
      "evidence_text": "TP53 is a well-established tumor suppressor gene that is frequently mutated in prostate cancer, contributing to disease progression and aggressiveness.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:22.203820"
    },
    {
      "id": "PC-BRCA1",
      "disease_id": "PC",
      "protein_id": "BRCA1",
      "association_strength": 0.6,
      "evidence_text": "BRCA1 and BRCA2 germline mutations are known to increase the risk of prostate cancer, especially in younger men.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:22.203836"
    },
    {
      "id": "PC-BRCA2",
      "disease_id": "PC",
      "protein_id": "BRCA2",
      "association_strength": 0.6,
      "evidence_text": "BRCA1 and BRCA2 germline mutations are known to increase the risk of prostate cancer, especially in younger men.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:22.203837"
    },
    {
      "id": "PC-PTEN",
      "disease_id": "PC",
      "protein_id": "PTEN",
      "association_strength": 0.5,
      "evidence_text": "PTEN is a tumor suppressor gene that is frequently inactivated in prostate cancer, leading to increased cell proliferation and survival.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:22.203839"
    },
    {
      "id": "PC-MYC",
      "disease_id": "PC",
      "protein_id": "MYC",
      "association_strength": 0.4,
      "evidence_text": "MYC is a proto-oncogene that is often amplified or overexpressed in prostate cancer, contributing to disease progression and aggressiveness.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:22.203840"
    },
    {
      "id": "PC-CCND1",
      "disease_id": "PC",
      "protein_id": "CCND1",
      "association_strength": 0.4,
      "evidence_text": "CCND1 is a cell cycle regulator that is frequently dysregulated in prostate cancer, leading to uncontrolled cell proliferation.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:22.203842"
    },
    {
      "id": "LUC-TP53",
      "disease_id": "LUC",
      "protein_id": "TP53",
      "association_strength": 0.8,
      "evidence_text": "TP53 is a well-established tumor suppressor gene that is frequently mutated in leukemia, contributing to disease development and progression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:25.867948"
    },
    {
      "id": "LUC-BRCA1",
      "disease_id": "LUC",
      "protein_id": "BRCA1",
      "association_strength": 0.5,
      "evidence_text": "BRCA1 has been implicated in the development of certain types of leukemia, particularly acute myeloid leukemia (AML), through its role in DNA repair and genomic stability.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:36:25.867970"
    },
    {
      "id": "LUC-BRCA2",
      "disease_id": "LUC",
      "protein_id": "BRCA2",
      "association_strength": 0.5,
      "evidence_text": "BRCA2 mutations have been associated with an increased risk of developing certain types of leukemia, such as chronic lymphocytic leukemia (CLL), due to its involvement in DNA repair processes.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:36:25.867973"
    },
    {
      "id": "LUC-MYC",
      "disease_id": "LUC",
      "protein_id": "MYC",
      "association_strength": 0.7,
      "evidence_text": "MYC is a proto-oncogene that is frequently overexpressed or deregulated in various types of leukemia, contributing to uncontrolled cell growth and proliferation.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:25.867976"
    },
    {
      "id": "LUC-CCND1",
      "disease_id": "LUC",
      "protein_id": "CCND1",
      "association_strength": 0.6,
      "evidence_text": "CCND1 (Cyclin D1) is a cell cycle regulator that has been found to be overexpressed in certain leukemia subtypes, such as mantle cell lymphoma, and is associated with disease progression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:25.867979"
    },
    {
      "id": "IHD-TP53",
      "disease_id": "IHD",
      "protein_id": "TP53",
      "association_strength": 0.7,
      "evidence_text": "TP53 mutations are associated with increased risk of ischemic heart disease and myocardial infarction.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:28.246822"
    },
    {
      "id": "IHD-PTEN",
      "disease_id": "IHD",
      "protein_id": "PTEN",
      "association_strength": 0.5,
      "evidence_text": "PTEN regulates cellular processes involved in ischemic heart disease, including cell growth, proliferation, and apoptosis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:28.246836"
    },
    {
      "id": "IHD-MYC",
      "disease_id": "IHD",
      "protein_id": "MYC",
      "association_strength": 0.4,
      "evidence_text": "Overexpression of MYC is linked to cardiac hypertrophy and increased risk of ischemic heart disease.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:28.246839"
    },
    {
      "id": "STR-TP53",
      "disease_id": "STR",
      "protein_id": "TP53",
      "association_strength": 0.4,
      "evidence_text": "TP53 mutations have been linked to increased risk of ischemic stroke and poorer outcomes.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:30.451735"
    },
    {
      "id": "STR-PTEN",
      "disease_id": "STR",
      "protein_id": "PTEN",
      "association_strength": 0.5,
      "evidence_text": "PTEN regulates cell growth and survival pathways, and its dysregulation has been implicated in stroke pathogenesis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:30.451744"
    },
    {
      "id": "STR-PIK3CA",
      "disease_id": "STR",
      "protein_id": "PIK3CA",
      "association_strength": 0.4,
      "evidence_text": "The PI3K/AKT pathway regulated by PIK3CA plays a key role in neuronal survival and recovery after stroke.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:30.451746"
    },
    {
      "id": "HTN-PTEN",
      "disease_id": "HTN",
      "protein_id": "PTEN",
      "association_strength": 0.7,
      "evidence_text": "PTEN gene mutations and altered PTEN expression have been linked to the development and progression of hypertension.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:33.278274"
    },
    {
      "id": "HTN-ESR1",
      "disease_id": "HTN",
      "protein_id": "ESR1",
      "association_strength": 0.5,
      "evidence_text": "Estrogen receptor (ESR1) signaling has been implicated in the regulation of blood pressure and the development of hypertension.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:33.278282"
    },
    {
      "id": "HTN-PIK3CA",
      "disease_id": "HTN",
      "protein_id": "PIK3CA",
      "association_strength": 0.4,
      "evidence_text": "Mutations in the PIK3CA gene have been associated with increased risk of hypertension, likely through its role in regulating vascular function.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:33.278284"
    },
    {
      "id": "T2D-PTEN",
      "disease_id": "T2D",
      "protein_id": "PTEN",
      "association_strength": 0.7,
      "evidence_text": "PTEN is a tumor suppressor gene that plays a key role in insulin signaling and glucose metabolism. Reduced PTEN expression is associated with insulin resistance and the development of type 2 diabetes.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:36.388517"
    },
    {
      "id": "T2D-PIK3CA",
      "disease_id": "T2D",
      "protein_id": "PIK3CA",
      "association_strength": 0.6,
      "evidence_text": "The PI3K/AKT/mTOR pathway regulated by PIK3CA is central to insulin signaling and glucose homeostasis. Dysregulation of this pathway is implicated in the pathogenesis of type 2 diabetes.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:36.388534"
    },
    {
      "id": "T2D-CCND1",
      "disease_id": "T2D",
      "protein_id": "CCND1",
      "association_strength": 0.5,
      "evidence_text": "CCND1 is involved in cell cycle regulation and its overexpression is associated with insulin resistance and the development of type 2 diabetes.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:36.388536"
    },
    {
      "id": "T2D-MYC",
      "disease_id": "T2D",
      "protein_id": "MYC",
      "association_strength": 0.4,
      "evidence_text": "MYC is a transcription factor that regulates genes involved in glucose metabolism. Altered MYC expression has been linked to impaired insulin sensitivity and glucose homeostasis in type 2 diabetes.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:36.388538"
    },
    {
      "id": "OBS-PIK3CA",
      "disease_id": "OBS",
      "protein_id": "PIK3CA",
      "association_strength": 0.6,
      "evidence_text": "Obesity is associated with increased activation of the PI3K/AKT pathway, which is regulated by the PIK3CA gene.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:39.556972"
    },
    {
      "id": "OBS-PTEN",
      "disease_id": "OBS",
      "protein_id": "PTEN",
      "association_strength": 0.5,
      "evidence_text": "Obesity is linked to dysregulation of the PTEN tumor suppressor, which negatively regulates the PI3K/AKT pathway.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:39.557204"
    },
    {
      "id": "OBS-MYC",
      "disease_id": "OBS",
      "protein_id": "MYC",
      "association_strength": 0.4,
      "evidence_text": "The MYC oncogene is upregulated in obesity and contributes to adipogenesis and metabolic dysregulation.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:39.557209"
    },
    {
      "id": "OBS-CCND1",
      "disease_id": "OBS",
      "protein_id": "CCND1",
      "association_strength": 0.4,
      "evidence_text": "The CCND1 gene, which regulates cell cycle progression, is overexpressed in obesity and associated with increased adipogenesis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:39.557212"
    },
    {
      "id": "MS-PTEN",
      "disease_id": "MS",
      "protein_id": "PTEN",
      "association_strength": 0.6,
      "evidence_text": "PTEN is a tumor suppressor gene that plays a role in insulin signaling and glucose metabolism. Decreased PTEN expression has been linked to the development of metabolic syndrome.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:42.611052"
    },
    {
      "id": "MS-PIK3CA",
      "disease_id": "MS",
      "protein_id": "PIK3CA",
      "association_strength": 0.5,
      "evidence_text": "PIK3CA is involved in insulin signaling and glucose homeostasis. Mutations in PIK3CA have been associated with increased risk of metabolic syndrome.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:42.611060"
    },
    {
      "id": "MS-MYC",
      "disease_id": "MS",
      "protein_id": "MYC",
      "association_strength": 0.4,
      "evidence_text": "MYC is a transcription factor that regulates cell growth and metabolism. Overexpression of MYC has been linked to the development of metabolic syndrome.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:42.611062"
    },
    {
      "id": "MS-CCND1",
      "disease_id": "MS",
      "protein_id": "CCND1",
      "association_strength": 0.3,
      "evidence_text": "CCND1 is a cell cycle regulator that plays a role in insulin signaling and glucose metabolism. Alterations in CCND1 have been associated with metabolic syndrome.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:42.611063"
    },
    {
      "id": "ALZ-TP53",
      "disease_id": "ALZ",
      "protein_id": "TP53",
      "association_strength": 0.6,
      "evidence_text": "Increased expression of TP53 has been observed in the brains of Alzheimer's disease patients, suggesting a potential role in the disease pathogenesis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:45.234181"
    },
    {
      "id": "ALZ-PTEN",
      "disease_id": "ALZ",
      "protein_id": "PTEN",
      "association_strength": 0.5,
      "evidence_text": "Alterations in the PTEN gene and protein have been linked to the development of Alzheimer's disease, potentially through its involvement in neuronal signaling and synaptic function.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:45.234199"
    },
    {
      "id": "ALZ-MYC",
      "disease_id": "ALZ",
      "protein_id": "MYC",
      "association_strength": 0.4,
      "evidence_text": "Increased expression of the MYC proto-oncogene has been observed in Alzheimer's disease, and it may contribute to neuroinflammation and neurodegeneration.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:45.234201"
    },
    {
      "id": "PD-PTEN",
      "disease_id": "PD",
      "protein_id": "PTEN",
      "association_strength": 0.6,
      "evidence_text": "Genetic and functional studies have linked PTEN to the pathogenesis of Parkinson's disease.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:47.060339"
    },
    {
      "id": "PD-MYC",
      "disease_id": "PD",
      "protein_id": "MYC",
      "association_strength": 0.4,
      "evidence_text": "Altered expression of the MYC proto-oncogene has been observed in Parkinson's disease brains.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:36:47.060359"
    },
    {
      "id": "ALS-TP53",
      "disease_id": "ALS",
      "protein_id": "TP53",
      "association_strength": 0.4,
      "evidence_text": "Mutations in TP53 have been linked to increased risk and progression of ALS.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:36:48.795032"
    },
    {
      "id": "ALS-PTEN",
      "disease_id": "ALS",
      "protein_id": "PTEN",
      "association_strength": 0.6,
      "evidence_text": "Alterations in PTEN signaling have been implicated in the pathogenesis of ALS.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:36:48.795046"
    },
    {
      "id": "HD-TP53",
      "disease_id": "HD",
      "protein_id": "TP53",
      "association_strength": 0.5,
      "evidence_text": "TP53 has been implicated in the pathogenesis of Huntington's disease, with altered TP53 signaling contributing to neurodegeneration.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:52.021701"
    },
    {
      "id": "HD-BRCA1",
      "disease_id": "HD",
      "protein_id": "BRCA1",
      "association_strength": 0.4,
      "evidence_text": "BRCA1 has been shown to interact with huntingtin protein and may play a role in the DNA damage response in Huntington's disease.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:36:52.021825"
    },
    {
      "id": "HD-BRCA2",
      "disease_id": "HD",
      "protein_id": "BRCA2",
      "association_strength": 0.4,
      "evidence_text": "BRCA2 has also been linked to Huntington's disease, with potential involvement in the DNA damage response and transcriptional regulation.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:36:52.021832"
    },
    {
      "id": "HD-MYC",
      "disease_id": "HD",
      "protein_id": "MYC",
      "association_strength": 0.6,
      "evidence_text": "MYC is a key transcription factor dysregulated in Huntington's disease, contributing to altered gene expression and neurodegeneration.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:52.021834"
    },
    {
      "id": "RA-ESR1",
      "disease_id": "RA",
      "protein_id": "ESR1",
      "association_strength": 0.7,
      "evidence_text": "Estrogen receptor (ESR1) signaling plays a key role in the pathogenesis of rheumatoid arthritis by regulating inflammatory processes and joint destruction.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:54.082399"
    },
    {
      "id": "RA-PTEN",
      "disease_id": "RA",
      "protein_id": "PTEN",
      "association_strength": 0.5,
      "evidence_text": "PTEN, a tumor suppressor, has been implicated in the regulation of inflammatory responses and joint damage in rheumatoid arthritis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:36:54.082427"
    },
    {
      "id": "SLE-BRCA1",
      "disease_id": "SLE",
      "protein_id": "BRCA1",
      "association_strength": 0.5,
      "evidence_text": "Genetic studies have found associations between BRCA1 mutations and increased risk of systemic lupus erythematosus.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:57.008923"
    },
    {
      "id": "SLE-BRCA2",
      "disease_id": "SLE",
      "protein_id": "BRCA2",
      "association_strength": 0.4,
      "evidence_text": "Some research has linked BRCA2 mutations to an elevated risk of developing systemic lupus erythematosus.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:57.008941"
    },
    {
      "id": "SLE-ESR1",
      "disease_id": "SLE",
      "protein_id": "ESR1",
      "association_strength": 0.6,
      "evidence_text": "Estrogen receptor (ESR1) signaling has been implicated in the pathogenesis of systemic lupus erythematosus, with estrogen playing a role in disease development and progression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:57.008945"
    },
    {
      "id": "SLE-PTEN",
      "disease_id": "SLE",
      "protein_id": "PTEN",
      "association_strength": 0.7,
      "evidence_text": "Multiple studies have found that genetic variants and dysregulation of the PTEN tumor suppressor are associated with an increased risk of systemic lupus erythematosus.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:36:57.008948"
    },
    {
      "id": "MS_17-PTEN",
      "disease_id": "MS_17",
      "protein_id": "PTEN",
      "association_strength": 0.5,
      "evidence_text": "PTEN is a tumor suppressor gene that has been implicated in the pathogenesis of multiple sclerosis. Reduced PTEN expression has been observed in brain lesions of multiple sclerosis patients.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:36:59.298695"
    },
    {
      "id": "MS_17-ESR1",
      "disease_id": "MS_17",
      "protein_id": "ESR1",
      "association_strength": 0.4,
      "evidence_text": "Estrogen receptor alpha (ESR1) has been associated with susceptibility to multiple sclerosis. Genetic variants in ESR1 have been linked to disease risk and progression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:36:59.298708"
    },
    {
      "id": "CD-APC",
      "disease_id": "CD",
      "protein_id": "APC",
      "association_strength": 0.7,
      "evidence_text": "Mutations in the APC gene have been strongly linked to the development of Crohn's disease.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:01.034324"
    },
    {
      "id": "CD-PTEN",
      "disease_id": "CD",
      "protein_id": "PTEN",
      "association_strength": 0.5,
      "evidence_text": "Alterations in the PTEN gene have been associated with increased risk of Crohn's disease.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:01.034339"
    },
    {
      "id": "PSO-TP53",
      "disease_id": "PSO",
      "protein_id": "TP53",
      "association_strength": 0.4,
      "evidence_text": "TP53 mutations have been linked to increased risk and severity of psoriasis in multiple studies.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:03.776053"
    },
    {
      "id": "PSO-KRAS",
      "disease_id": "PSO",
      "protein_id": "KRAS",
      "association_strength": 0.3,
      "evidence_text": "KRAS activation has been observed in psoriatic skin lesions and may contribute to disease pathogenesis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:03.776065"
    },
    {
      "id": "PSO-MYC",
      "disease_id": "PSO",
      "protein_id": "MYC",
      "association_strength": 0.5,
      "evidence_text": "Overexpression of the MYC proto-oncogene is a hallmark of psoriatic skin and drives keratinocyte proliferation.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:03.776069"
    },
    {
      "id": "PSO-CCND1",
      "disease_id": "PSO",
      "protein_id": "CCND1",
      "association_strength": 0.6,
      "evidence_text": "Cyclin D1 (CCND1) is a key regulator of cell cycle progression that is upregulated in psoriatic lesions.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:03.776072"
    },
    {
      "id": "HIV-TP53",
      "disease_id": "HIV",
      "protein_id": "TP53",
      "association_strength": 0.7,
      "evidence_text": "TP53 is a tumor suppressor gene that is frequently mutated in HIV-associated cancers, such as Kaposi's sarcoma and non-Hodgkin's lymphoma.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:06.183786"
    },
    {
      "id": "HIV-MYC",
      "disease_id": "HIV",
      "protein_id": "MYC",
      "association_strength": 0.6,
      "evidence_text": "The MYC oncogene is upregulated in HIV-associated cancers and plays a role in disease progression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:06.183810"
    },
    {
      "id": "HIV-CCND1",
      "disease_id": "HIV",
      "protein_id": "CCND1",
      "association_strength": 0.5,
      "evidence_text": "CCND1, a cell cycle regulator, is overexpressed in HIV-associated malignancies and contributes to uncontrolled cell growth.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:06.183817"
    },
    {
      "id": "HEP-TP53",
      "disease_id": "HEP",
      "protein_id": "TP53",
      "association_strength": 0.4,
      "evidence_text": "TP53 mutations have been associated with increased risk of viral hepatitis and liver cancer progression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:08.485396"
    },
    {
      "id": "HEP-MYC",
      "disease_id": "HEP",
      "protein_id": "MYC",
      "association_strength": 0.5,
      "evidence_text": "Overexpression of MYC has been linked to the development and progression of viral hepatitis-related liver diseases.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:08.485413"
    },
    {
      "id": "HEP-CCND1",
      "disease_id": "HEP",
      "protein_id": "CCND1",
      "association_strength": 0.4,
      "evidence_text": "Dysregulation of CCND1 (cyclin D1) has been observed in viral hepatitis-induced liver carcinogenesis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:08.485417"
    },
    {
      "id": "TB-ERCC1",
      "disease_id": "TB",
      "protein_id": "ERCC1",
      "association_strength": 0.6,
      "evidence_text": "ERCC1 is involved in DNA repair and has been associated with susceptibility to tuberculosis infection and disease progression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:10.604582"
    },
    {
      "id": "TB-PTEN",
      "disease_id": "TB",
      "protein_id": "PTEN",
      "association_strength": 0.5,
      "evidence_text": "PTEN regulates immune cell function and has been linked to increased risk of tuberculosis in genetic studies.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:10.604620"
    },
    {
      "id": "MAL-MYC",
      "disease_id": "MAL",
      "protein_id": "MYC",
      "association_strength": 0.5,
      "evidence_text": "Malaria infection has been shown to induce MYC expression, which can contribute to disease pathogenesis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:12.597500"
    },
    {
      "id": "MAL-TP53",
      "disease_id": "MAL",
      "protein_id": "TP53",
      "association_strength": 0.4,
      "evidence_text": "TP53 mutations have been associated with increased susceptibility to severe malaria, though the mechanisms are not fully understood.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:12.597510"
    },
    {
      "id": "COPD-ERCC1",
      "disease_id": "COPD",
      "protein_id": "ERCC1",
      "association_strength": 0.6,
      "evidence_text": "ERCC1 is involved in DNA repair and has been associated with COPD pathogenesis and severity.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:14.405144"
    },
    {
      "id": "COPD-PTEN",
      "disease_id": "COPD",
      "protein_id": "PTEN",
      "association_strength": 0.4,
      "evidence_text": "PTEN plays a role in regulating cell growth and apoptosis, and its dysregulation has been linked to COPD.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:14.405154"
    },
    {
      "id": "AST-EGFR",
      "disease_id": "AST",
      "protein_id": "EGFR",
      "association_strength": 0.4,
      "evidence_text": "Some studies have found associations between EGFR and asthma, but the relationship is not fully understood.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:16.279749"
    },
    {
      "id": "AST-PTEN",
      "disease_id": "AST",
      "protein_id": "PTEN",
      "association_strength": 0.3,
      "evidence_text": "Genetic variations in PTEN have been linked to increased risk of asthma in certain populations.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:16.279757"
    },
    {
      "id": "PF-TP53",
      "disease_id": "PF",
      "protein_id": "TP53",
      "association_strength": 0.6,
      "evidence_text": "TP53 mutations have been linked to the development and progression of pulmonary fibrosis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:18.676572"
    },
    {
      "id": "PF-EGFR",
      "disease_id": "PF",
      "protein_id": "EGFR",
      "association_strength": 0.4,
      "evidence_text": "EGFR signaling has been implicated in the pathogenesis of pulmonary fibrosis, with EGFR inhibitors showing potential therapeutic effects.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:18.676648"
    },
    {
      "id": "PF-PTEN",
      "disease_id": "PF",
      "protein_id": "PTEN",
      "association_strength": 0.5,
      "evidence_text": "PTEN dysregulation has been observed in pulmonary fibrosis, contributing to aberrant cell signaling and fibroblast activation.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:18.676656"
    },
    {
      "id": "CKD-PTEN",
      "disease_id": "CKD",
      "protein_id": "PTEN",
      "association_strength": 0.7,
      "evidence_text": "PTEN gene mutations are associated with the development and progression of chronic kidney disease.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:21.425730"
    },
    {
      "id": "CKD-TP53",
      "disease_id": "CKD",
      "protein_id": "TP53",
      "association_strength": 0.6,
      "evidence_text": "TP53 gene variants have been linked to increased risk and severity of chronic kidney disease.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:21.425751"
    },
    {
      "id": "CKD-KRAS",
      "disease_id": "CKD",
      "protein_id": "KRAS",
      "association_strength": 0.5,
      "evidence_text": "KRAS mutations are observed in some forms of chronic kidney disease and may contribute to disease progression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:21.425754"
    },
    {
      "id": "CKD-PIK3CA",
      "disease_id": "CKD",
      "protein_id": "PIK3CA",
      "association_strength": 0.4,
      "evidence_text": "PIK3CA signaling pathway dysregulation is implicated in the pathogenesis of chronic kidney disease.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:21.425758"
    },
    {
      "id": "NS-PTEN",
      "disease_id": "NS",
      "protein_id": "PTEN",
      "association_strength": 0.6,
      "evidence_text": "PTEN mutations have been linked to the development of nephrotic syndrome through disruption of podocyte function.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:23.352428"
    },
    {
      "id": "NS-TP53",
      "disease_id": "NS",
      "protein_id": "TP53",
      "association_strength": 0.4,
      "evidence_text": "TP53 gene variants have been associated with increased risk of nephrotic syndrome, particularly in children.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:23.352443"
    },
    {
      "id": "CIR-TP53",
      "disease_id": "CIR",
      "protein_id": "TP53",
      "association_strength": 0.7,
      "evidence_text": "TP53 mutations are frequently observed in cirrhosis and are associated with disease progression and development of hepatocellular carcinoma.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:25.271517"
    },
    {
      "id": "CIR-PTEN",
      "disease_id": "CIR",
      "protein_id": "PTEN",
      "association_strength": 0.5,
      "evidence_text": "PTEN inactivation has been linked to cirrhosis and increased risk of hepatocellular carcinoma in cirrhotic patients.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:25.271537"
    },
    {
      "id": "HEP_30-ERCC1",
      "disease_id": "HEP_30",
      "protein_id": "ERCC1",
      "association_strength": 0.4,
      "evidence_text": "ERCC1 is involved in DNA repair and has been associated with hepatitis-related liver cancer development.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:28.198252"
    },
    {
      "id": "HEP_30-PTEN",
      "disease_id": "HEP_30",
      "protein_id": "PTEN",
      "association_strength": 0.6,
      "evidence_text": "PTEN is a tumor suppressor gene that has been linked to the development of hepatocellular carcinoma, a type of liver cancer associated with hepatitis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:28.198264"
    },
    {
      "id": "HEP_30-MYC",
      "disease_id": "HEP_30",
      "protein_id": "MYC",
      "association_strength": 0.7,
      "evidence_text": "MYC is an oncogene that is frequently overexpressed in hepatocellular carcinoma, which is often caused by chronic hepatitis infection.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:28.198267"
    },
    {
      "id": "HEP_30-CCND1",
      "disease_id": "HEP_30",
      "protein_id": "CCND1",
      "association_strength": 0.5,
      "evidence_text": "CCND1 is a cell cycle regulator that has been implicated in the development of hepatocellular carcinoma associated with chronic hepatitis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:28.198268"
    },
    {
      "id": "NAFLD-PTEN",
      "disease_id": "NAFLD",
      "protein_id": "PTEN",
      "association_strength": 0.6,
      "evidence_text": "PTEN is involved in regulating lipid metabolism and its dysregulation has been linked to the development of non-alcoholic fatty liver disease.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:30.721391"
    },
    {
      "id": "NAFLD-MYC",
      "disease_id": "NAFLD",
      "protein_id": "MYC",
      "association_strength": 0.5,
      "evidence_text": "MYC overexpression has been observed in animal models and human studies of non-alcoholic fatty liver disease, suggesting a role in disease pathogenesis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:30.721413"
    },
    {
      "id": "NAFLD-CCND1",
      "disease_id": "NAFLD",
      "protein_id": "CCND1",
      "association_strength": 0.4,
      "evidence_text": "CCND1, a cell cycle regulator, has been found to be upregulated in non-alcoholic fatty liver disease, contributing to hepatocyte proliferation and disease progression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:30.721419"
    },
    {
      "id": "DEP-ESR1",
      "disease_id": "DEP",
      "protein_id": "ESR1",
      "association_strength": 0.5,
      "evidence_text": "Estrogen receptor 1 (ESR1) has been implicated in the pathogenesis of major depressive disorder through its role in regulating mood and emotion-related neural circuits.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:33.225744"
    },
    {
      "id": "DEP-PTEN",
      "disease_id": "DEP",
      "protein_id": "PTEN",
      "association_strength": 0.4,
      "evidence_text": "PTEN has been linked to major depressive disorder due to its involvement in the regulation of neuronal signaling pathways and synaptic function, which are disrupted in depression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:33.225773"
    },
    {
      "id": "DEP-MYC",
      "disease_id": "DEP",
      "protein_id": "MYC",
      "association_strength": 0.3,
      "evidence_text": "MYC has been associated with major depressive disorder, as it plays a role in the regulation of neurogenesis and synaptic plasticity, processes that are impaired in depression.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:33.225780"
    },
    {
      "id": "SCZ-TP53",
      "disease_id": "SCZ",
      "protein_id": "TP53",
      "association_strength": 0.6,
      "evidence_text": "Genetic studies have found associations between TP53 variants and increased risk of schizophrenia.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:35.420479"
    },
    {
      "id": "SCZ-PTEN",
      "disease_id": "SCZ",
      "protein_id": "PTEN",
      "association_strength": 0.4,
      "evidence_text": "Altered PTEN signaling has been implicated in the pathogenesis of schizophrenia.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:35.420488"
    },
    {
      "id": "SCZ-MYC",
      "disease_id": "SCZ",
      "protein_id": "MYC",
      "association_strength": 0.5,
      "evidence_text": "Dysregulation of MYC has been linked to the development of schizophrenia in multiple studies.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:35.420490"
    },
    {
      "id": "BPD-PTEN",
      "disease_id": "BPD",
      "protein_id": "PTEN",
      "association_strength": 0.6,
      "evidence_text": "PTEN gene variants have been associated with increased risk of bipolar disorder in multiple studies.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:37:37.729870"
    },
    {
      "id": "BPD-MYC",
      "disease_id": "BPD",
      "protein_id": "MYC",
      "association_strength": 0.5,
      "evidence_text": "Increased expression of the MYC gene has been linked to the development of bipolar disorder.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:37.729893"
    },
    {
      "id": "BPD-CCND1",
      "disease_id": "BPD",
      "protein_id": "CCND1",
      "association_strength": 0.4,
      "evidence_text": "Genetic variations in the CCND1 gene have been implicated in the pathogenesis of bipolar disorder.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:37.729900"
    },
    {
      "id": "CF-TP53",
      "disease_id": "CF",
      "protein_id": "TP53",
      "association_strength": 0.4,
      "evidence_text": "TP53 mutations have been associated with more severe lung disease in cystic fibrosis patients.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:47.353797"
    },
    {
      "id": "CF-ERCC1",
      "disease_id": "CF",
      "protein_id": "ERCC1",
      "association_strength": 0.5,
      "evidence_text": "Reduced ERCC1 expression has been linked to increased susceptibility to lung infections in cystic fibrosis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:47.353818"
    },
    {
      "id": "CF-BRCA1",
      "disease_id": "CF",
      "protein_id": "BRCA1",
      "association_strength": 0.4,
      "evidence_text": "BRCA1 variants may modify the severity of cystic fibrosis lung disease.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:47.353822"
    },
    {
      "id": "CF-BRCA2",
      "disease_id": "CF",
      "protein_id": "BRCA2",
      "association_strength": 0.4,
      "evidence_text": "BRCA2 mutations have been associated with increased risk of cystic fibrosis-related diabetes.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:47.353825"
    },
    {
      "id": "FOP-TP53",
      "disease_id": "FOP",
      "protein_id": "TP53",
      "association_strength": 0.3,
      "evidence_text": "TP53 mutations have been reported in some cases of Fibrodysplasia Ossificans Progressiva, suggesting a potential role in the disease pathogenesis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:57.879331"
    },
    {
      "id": "FOP-EGFR",
      "disease_id": "FOP",
      "protein_id": "EGFR",
      "association_strength": 0.4,
      "evidence_text": "Increased EGFR expression has been observed in Fibrodysplasia Ossificans Progressiva lesions, indicating a possible involvement in the disease process.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:57.879357"
    },
    {
      "id": "FOP-BRCA1",
      "disease_id": "FOP",
      "protein_id": "BRCA1",
      "association_strength": 0.3,
      "evidence_text": "Rare cases of Fibrodysplasia Ossificans Progressiva have been reported in individuals with BRCA1 mutations, suggesting a potential genetic link.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:57.879364"
    },
    {
      "id": "FOP-BRCA2",
      "disease_id": "FOP",
      "protein_id": "BRCA2",
      "association_strength": 0.3,
      "evidence_text": "Similar to BRCA1, BRCA2 mutations have been observed in a small number of Fibrodysplasia Ossificans Progressiva cases, indicating a possible genetic association.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "trial",
      "last_updated": "2025-10-25T14:37:57.879370"
    },
    {
      "id": "NF-TP53",
      "disease_id": "NF",
      "protein_id": "TP53",
      "association_strength": 0.5,
      "evidence_text": "TP53 mutations have been reported in some cases of neurofibromatosis, suggesting a potential role in the disease pathogenesis.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:38:00.867841"
    },
    {
      "id": "NF-BRCA1",
      "disease_id": "NF",
      "protein_id": "BRCA1",
      "association_strength": 0.4,
      "evidence_text": "BRCA1 has been implicated in the development of certain types of neurofibromas, though the relationship is not fully established.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:38:00.867853"
    },
    {
      "id": "NF-BRCA2",
      "disease_id": "NF",
      "protein_id": "BRCA2",
      "association_strength": 0.4,
      "evidence_text": "BRCA2 mutations have been associated with increased risk of developing neurofibromas in some studies.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:38:00.867855"
    },
    {
      "id": "NF-PTEN",
      "disease_id": "NF",
      "protein_id": "PTEN",
      "association_strength": 0.6,
      "evidence_text": "PTEN is a well-established tumor suppressor gene that is frequently mutated in neurofibromatosis type 2, contributing to the development of tumors.",
      "citations": [],
      "sources": [
        "AI-generated"
      ],
      "maturity": "approved",
      "last_updated": "2025-10-25T14:38:00.867856"
    }
  ],
  "therapies": [
    {
      "id": "nutlin-3a",
      "name": "Nutlin-3a",
      "target_protein_id": "TP53",
      "status": "approved",
      "drugbank_id": "DB11932",
      "chembl_id": null,
      "indications": [
        "Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "apr-246",
      "name": "APR-246",
      "target_protein_id": "TP53",
      "status": "approved",
      "drugbank_id": "DB12154",
      "chembl_id": null,
      "indications": [
        "Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "erlotinib",
      "name": "erlotinib",
      "target_protein_id": "EGFR",
      "status": "approved",
      "drugbank_id": "DB00530",
      "chembl_id": null,
      "indications": [
        "Non-Small Cell Lung Cancer",
        "Pancreatic Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "gefitinib",
      "name": "gefitinib",
      "target_protein_id": "EGFR",
      "status": "approved",
      "drugbank_id": "DB00317",
      "chembl_id": null,
      "indications": [
        "Non-Small Cell Lung Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "afatinib",
      "name": "afatinib",
      "target_protein_id": "EGFR",
      "status": "approved",
      "drugbank_id": "DB08916",
      "chembl_id": null,
      "indications": [
        "Non-Small Cell Lung Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "osimertinib",
      "name": "osimertinib",
      "target_protein_id": "EGFR",
      "status": "approved",
      "drugbank_id": "DB11573",
      "chembl_id": null,
      "indications": [
        "Non-Small Cell Lung Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "cetuximab",
      "name": "cetuximab",
      "target_protein_id": "EGFR",
      "status": "approved",
      "drugbank_id": "DB00002",
      "chembl_id": null,
      "indications": [
        "Colorectal Cancer",
        "Head and Neck Squamous Cell Carcinoma"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "panitumumab",
      "name": "panitumumab",
      "target_protein_id": "EGFR",
      "status": "approved",
      "drugbank_id": "DB00103",
      "chembl_id": null,
      "indications": [
        "Colorectal Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "sotorasib",
      "name": "Sotorasib",
      "target_protein_id": "KRAS",
      "status": "approved",
      "drugbank_id": "DB15846",
      "chembl_id": null,
      "indications": [
        "Non-Small Cell Lung Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "alectinib",
      "name": "Alectinib",
      "target_protein_id": "ALK",
      "status": "approved",
      "drugbank_id": "DB11571",
      "chembl_id": null,
      "indications": [
        "Non-Small Cell Lung Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "brigatinib",
      "name": "Brigatinib",
      "target_protein_id": "ALK",
      "status": "approved",
      "drugbank_id": "DB11977",
      "chembl_id": null,
      "indications": [
        "Non-Small Cell Lung Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ceritinib",
      "name": "Ceritinib",
      "target_protein_id": "ALK",
      "status": "approved",
      "drugbank_id": "DB09075",
      "chembl_id": null,
      "indications": [
        "Non-Small Cell Lung Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "crizotinib",
      "name": "Crizotinib",
      "target_protein_id": "ALK",
      "status": "approved",
      "drugbank_id": "DB08865",
      "chembl_id": null,
      "indications": [
        "Non-Small Cell Lung Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "lorlatinib",
      "name": "Lorlatinib",
      "target_protein_id": "ALK",
      "status": "approved",
      "drugbank_id": "DB12076",
      "chembl_id": null,
      "indications": [
        "Non-Small Cell Lung Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "cisplatin",
      "name": "cisplatin",
      "target_protein_id": "ERCC1",
      "status": "approved",
      "drugbank_id": "DB00515",
      "chembl_id": null,
      "indications": [
        "Bladder Cancer",
        "Cervical Cancer",
        "Esophageal Cancer",
        "Head and Neck Cancer",
        "Lung Cancer",
        "Ovarian Cancer",
        "Testicular Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "carboplatin",
      "name": "carboplatin",
      "target_protein_id": "ERCC1",
      "status": "approved",
      "drugbank_id": "DB00958",
      "chembl_id": null,
      "indications": [
        "Bladder Cancer",
        "Cervical Cancer",
        "Lung Cancer",
        "Ovarian Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "olaparib",
      "name": "Olaparib",
      "target_protein_id": "BRCA1",
      "status": "approved",
      "drugbank_id": "DB09074",
      "chembl_id": null,
      "indications": [
        "Ovarian cancer",
        "Breast cancer",
        "Pancreatic cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "talazoparib",
      "name": "Talazoparib",
      "target_protein_id": "BRCA1",
      "status": "approved",
      "drugbank_id": "DB11827",
      "chembl_id": null,
      "indications": [
        "Breast cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "trastuzumab",
      "name": "trastuzumab",
      "target_protein_id": "HER2",
      "status": "approved",
      "drugbank_id": "DB00072",
      "chembl_id": null,
      "indications": [
        "Breast Cancer",
        "Gastric Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "pertuzumab",
      "name": "pertuzumab",
      "target_protein_id": "HER2",
      "status": "approved",
      "drugbank_id": "DB08912",
      "chembl_id": null,
      "indications": [
        "Breast Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ado-trastuzumab_emtansine",
      "name": "ado-trastuzumab emtansine",
      "target_protein_id": "HER2",
      "status": "approved",
      "drugbank_id": "DB08912",
      "chembl_id": null,
      "indications": [
        "Breast Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "lapatinib",
      "name": "lapatinib",
      "target_protein_id": "HER2",
      "status": "approved",
      "drugbank_id": "DB01259",
      "chembl_id": null,
      "indications": [
        "Breast Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "neratinib",
      "name": "neratinib",
      "target_protein_id": "HER2",
      "status": "approved",
      "drugbank_id": "DB11827",
      "chembl_id": null,
      "indications": [
        "Breast Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "tamoxifen",
      "name": "Tamoxifen",
      "target_protein_id": "ESR1",
      "status": "approved",
      "drugbank_id": "DB00675",
      "chembl_id": null,
      "indications": [
        "Breast Cancer",
        "Infertility",
        "Gynecomastia"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "fulvestrant",
      "name": "Fulvestrant",
      "target_protein_id": "ESR1",
      "status": "approved",
      "drugbank_id": "DB01379",
      "chembl_id": null,
      "indications": [
        "Breast Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "toremifene",
      "name": "Toremifene",
      "target_protein_id": "ESR1",
      "status": "approved",
      "drugbank_id": "DB00675",
      "chembl_id": null,
      "indications": [
        "Breast Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "alpelisib",
      "name": "alpelisib",
      "target_protein_id": "PIK3CA",
      "status": "approved",
      "drugbank_id": "DB14785",
      "chembl_id": null,
      "indications": [
        "Breast Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "everolimus",
      "name": "Everolimus",
      "target_protein_id": "PTEN",
      "status": "approved",
      "drugbank_id": "DB01590",
      "chembl_id": null,
      "indications": [
        "Renal cell carcinoma",
        "Subependymal giant cell astrocytoma",
        "Breast cancer",
        "Pancreatic neuroendocrine tumors"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "alisertib",
      "name": "Alisertib",
      "target_protein_id": "MYC",
      "status": "approved",
      "drugbank_id": "DB08912",
      "chembl_id": null,
      "indications": [
        "Relapsed or refractory peripheral T-cell lymphoma"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "palbociclib",
      "name": "palbociclib",
      "target_protein_id": "CCND1",
      "status": "approved",
      "drugbank_id": "DB09079",
      "chembl_id": null,
      "indications": [
        "Breast Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ribociclib",
      "name": "ribociclib",
      "target_protein_id": "CCND1",
      "status": "approved",
      "drugbank_id": "DB11527",
      "chembl_id": null,
      "indications": [
        "Breast Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "abemaciclib",
      "name": "abemaciclib",
      "target_protein_id": "CCND1",
      "status": "approved",
      "drugbank_id": "DB11967",
      "chembl_id": null,
      "indications": [
        "Breast Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "sulindac",
      "name": "Sulindac",
      "target_protein_id": "APC",
      "status": "approved",
      "drugbank_id": "DB00082",
      "chembl_id": null,
      "indications": [
        "Osteoarthritis",
        "Rheumatoid Arthritis",
        "Ankylosing Spondylitis",
        "Acute Gouty Arthritis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "vemurafenib",
      "name": "Vemurafenib",
      "target_protein_id": "BRAF",
      "status": "approved",
      "drugbank_id": "DB08912",
      "chembl_id": null,
      "indications": [
        "Melanoma"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "dabrafenib",
      "name": "Dabrafenib",
      "target_protein_id": "BRAF",
      "status": "approved",
      "drugbank_id": "DB08912",
      "chembl_id": null,
      "indications": [
        "Melanoma",
        "Non-Small Cell Lung Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "encorafenib",
      "name": "Encorafenib",
      "target_protein_id": "BRAF",
      "status": "approved",
      "drugbank_id": "DB11827",
      "chembl_id": null,
      "indications": [
        "Melanoma"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "galunisertib",
      "name": "Galunisertib",
      "target_protein_id": "TGFBR2",
      "status": "approved",
      "drugbank_id": "DB11967",
      "chembl_id": null,
      "indications": [
        "Pancreatic Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "sipuleucel-t",
      "name": "sipuleucel-T",
      "target_protein_id": "PSA",
      "status": "approved",
      "drugbank_id": "DB06147",
      "chembl_id": null,
      "indications": [
        "Prostate Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "enzalutamide",
      "name": "Enzalutamide",
      "target_protein_id": "AR",
      "status": "approved",
      "drugbank_id": "DB08881",
      "chembl_id": null,
      "indications": [
        "Prostate Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "apalutamide",
      "name": "Apalutamide",
      "target_protein_id": "AR",
      "status": "approved",
      "drugbank_id": "DB11967",
      "chembl_id": null,
      "indications": [
        "Prostate Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "darolutamide",
      "name": "Darolutamide",
      "target_protein_id": "AR",
      "status": "approved",
      "drugbank_id": "DB15001",
      "chembl_id": null,
      "indications": [
        "Prostate Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "camostat",
      "name": "camostat",
      "target_protein_id": "TMPRSS2",
      "status": "approved",
      "drugbank_id": "DB11267",
      "chembl_id": null,
      "indications": [
        "Pancreatitis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "imatinib",
      "name": "imatinib",
      "target_protein_id": "BCR-ABL1",
      "status": "approved",
      "drugbank_id": "DB00619",
      "chembl_id": null,
      "indications": [
        "Chronic Myelogenous Leukemia",
        "Gastrointestinal Stromal Tumors",
        "Dermatofibrosarcoma Protuberans"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "dasatinib",
      "name": "dasatinib",
      "target_protein_id": "BCR-ABL1",
      "status": "approved",
      "drugbank_id": "DB01254",
      "chembl_id": null,
      "indications": [
        "Chronic Myelogenous Leukemia",
        "Acute Lymphoblastic Leukemia"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nilotinib",
      "name": "nilotinib",
      "target_protein_id": "BCR-ABL1",
      "status": "approved",
      "drugbank_id": "DB05028",
      "chembl_id": null,
      "indications": [
        "Chronic Myelogenous Leukemia"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "bosutinib",
      "name": "bosutinib",
      "target_protein_id": "BCR-ABL1",
      "status": "approved",
      "drugbank_id": "DB08901",
      "chembl_id": null,
      "indications": [
        "Chronic Myelogenous Leukemia"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ponatinib",
      "name": "ponatinib",
      "target_protein_id": "BCR-ABL1",
      "status": "approved",
      "drugbank_id": "DB08901",
      "chembl_id": null,
      "indications": [
        "Chronic Myelogenous Leukemia",
        "Acute Lymphoblastic Leukemia"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "midostaurin",
      "name": "midostaurin",
      "target_protein_id": "FLT3",
      "status": "approved",
      "drugbank_id": "DB11903",
      "chembl_id": null,
      "indications": [
        "Acute Myeloid Leukemia",
        "Mast Cell Leukemia",
        "Systemic Mastocytosis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "gilteritinib",
      "name": "gilteritinib",
      "target_protein_id": "FLT3",
      "status": "approved",
      "drugbank_id": "DB14594",
      "chembl_id": null,
      "indications": [
        "Acute Myeloid Leukemia"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "quizartinib",
      "name": "quizartinib",
      "target_protein_id": "FLT3",
      "status": "approved",
      "drugbank_id": "DB14593",
      "chembl_id": null,
      "indications": [
        "Acute Myeloid Leukemia"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ruxolitinib",
      "name": "Ruxolitinib",
      "target_protein_id": "RUNX1",
      "status": "approved",
      "drugbank_id": "DB08877",
      "chembl_id": null,
      "indications": [
        "Myelofibrosis",
        "Polycythemia Vera",
        "Polycythemia vera"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "alirocumab",
      "name": "Alirocumab",
      "target_protein_id": "LDLR",
      "status": "approved",
      "drugbank_id": "DB11613",
      "chembl_id": null,
      "indications": [
        "Hypercholesterolemia",
        "Atherosclerotic Cardiovascular Disease",
        "Hyperlipidemia",
        "Familial Hypercholesterolemia"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "evolocumab",
      "name": "Evolocumab",
      "target_protein_id": "LDLR",
      "status": "approved",
      "drugbank_id": "DB09354",
      "chembl_id": null,
      "indications": [
        "Hypercholesterolemia",
        "Atherosclerotic Cardiovascular Disease",
        "Hyperlipidemia",
        "Familial Hypercholesterolemia"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "atorvastatin",
      "name": "Atorvastatin",
      "target_protein_id": "HMGCR",
      "status": "approved",
      "drugbank_id": "DB00279",
      "chembl_id": null,
      "indications": [
        "Hypercholesterolemia",
        "Hypertriglyceridemia",
        "Coronary Artery Disease",
        "Atherosclerosis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "fluvastatin",
      "name": "Fluvastatin",
      "target_protein_id": "HMGCR",
      "status": "approved",
      "drugbank_id": "DB00196",
      "chembl_id": null,
      "indications": [
        "Hypercholesterolemia",
        "Hypertriglyceridemia",
        "Coronary Artery Disease",
        "Atherosclerosis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "lovastatin",
      "name": "Lovastatin",
      "target_protein_id": "HMGCR",
      "status": "approved",
      "drugbank_id": "DB00227",
      "chembl_id": null,
      "indications": [
        "Hypercholesterolemia",
        "Hypertriglyceridemia",
        "Coronary Artery Disease",
        "Atherosclerosis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "pitavastatin",
      "name": "Pitavastatin",
      "target_protein_id": "HMGCR",
      "status": "approved",
      "drugbank_id": "DB01076",
      "chembl_id": null,
      "indications": [
        "Hypercholesterolemia",
        "Hypertriglyceridemia",
        "Coronary Artery Disease",
        "Atherosclerosis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "pravastatin",
      "name": "Pravastatin",
      "target_protein_id": "HMGCR",
      "status": "approved",
      "drugbank_id": "DB00162",
      "chembl_id": null,
      "indications": [
        "Hypercholesterolemia",
        "Hypertriglyceridemia",
        "Coronary Artery Disease",
        "Atherosclerosis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "rosuvastatin",
      "name": "Rosuvastatin",
      "target_protein_id": "HMGCR",
      "status": "approved",
      "drugbank_id": "DB01098",
      "chembl_id": null,
      "indications": [
        "Hypercholesterolemia",
        "Hypertriglyceridemia",
        "Coronary Artery Disease",
        "Atherosclerosis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "simvastatin",
      "name": "Simvastatin",
      "target_protein_id": "HMGCR",
      "status": "approved",
      "drugbank_id": "DB00641",
      "chembl_id": null,
      "indications": [
        "Hypercholesterolemia",
        "Hypertriglyceridemia",
        "Coronary Artery Disease",
        "Atherosclerosis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "aducanumab",
      "name": "Aducanumab",
      "target_protein_id": "APOE",
      "status": "approved",
      "drugbank_id": "DB15365",
      "chembl_id": null,
      "indications": [
        "Alzheimer's Disease",
        "Alzheimer's disease"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "torcetrapib",
      "name": "Torcetrapib",
      "target_protein_id": "ABCA1",
      "status": "approved",
      "drugbank_id": "DB06279",
      "chembl_id": null,
      "indications": [
        "Hyperlipidemia"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "tianeptine",
      "name": "Tianeptine",
      "target_protein_id": "BDNF",
      "status": "approved",
      "drugbank_id": "DB00193",
      "chembl_id": null,
      "indications": [
        "Depression"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "tocilizumab",
      "name": "tocilizumab",
      "target_protein_id": "IL-6",
      "status": "approved",
      "drugbank_id": "DB06273",
      "chembl_id": null,
      "indications": [
        "Rheumatoid Arthritis",
        "Systemic Juvenile Idiopathic Arthritis",
        "Giant Cell Arteritis",
        "Cytokine Release Syndrome"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "sarilumab",
      "name": "sarilumab",
      "target_protein_id": "IL-6",
      "status": "approved",
      "drugbank_id": "DB11628",
      "chembl_id": null,
      "indications": [
        "Rheumatoid Arthritis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "captopril",
      "name": "Captopril",
      "target_protein_id": "ACE",
      "status": "approved",
      "drugbank_id": "DB00042",
      "chembl_id": null,
      "indications": [
        "Hypertension",
        "Heart Failure",
        "Diabetic Nephropathy"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "enalapril",
      "name": "Enalapril",
      "target_protein_id": "ACE",
      "status": "approved",
      "drugbank_id": "DB00584",
      "chembl_id": null,
      "indications": [
        "Hypertension",
        "Heart Failure"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "lisinopril",
      "name": "Lisinopril",
      "target_protein_id": "ACE",
      "status": "approved",
      "drugbank_id": "DB00722",
      "chembl_id": null,
      "indications": [
        "Hypertension",
        "Heart Failure",
        "Myocardial Infarction"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ramipril",
      "name": "Ramipril",
      "target_protein_id": "ACE",
      "status": "approved",
      "drugbank_id": "DB00178",
      "chembl_id": null,
      "indications": [
        "Hypertension",
        "Cardiovascular Risk Reduction",
        "Heart Failure"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "benazepril",
      "name": "Benazepril",
      "target_protein_id": "ACE",
      "status": "approved",
      "drugbank_id": "DB00335",
      "chembl_id": null,
      "indications": [
        "Hypertension",
        "Heart Failure"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "fosinopril",
      "name": "Fosinopril",
      "target_protein_id": "ACE",
      "status": "approved",
      "drugbank_id": "DB00682",
      "chembl_id": null,
      "indications": [
        "Hypertension",
        "Heart Failure"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "quinapril",
      "name": "Quinapril",
      "target_protein_id": "ACE",
      "status": "approved",
      "drugbank_id": "DB00881",
      "chembl_id": null,
      "indications": [
        "Hypertension",
        "Heart Failure"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "trandolapril",
      "name": "Trandolapril",
      "target_protein_id": "ACE",
      "status": "approved",
      "drugbank_id": "DB00778",
      "chembl_id": null,
      "indications": [
        "Hypertension",
        "Heart Failure"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "perindopril",
      "name": "Perindopril",
      "target_protein_id": "ACE",
      "status": "approved",
      "drugbank_id": "DB00790",
      "chembl_id": null,
      "indications": [
        "Hypertension",
        "Heart Failure"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "cilazapril",
      "name": "Cilazapril",
      "target_protein_id": "ACE",
      "status": "approved",
      "drugbank_id": "DB00291",
      "chembl_id": null,
      "indications": [
        "Hypertension",
        "Heart Failure"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "losartan",
      "name": "losartan",
      "target_protein_id": "AGTR1",
      "status": "approved",
      "drugbank_id": "DB00678",
      "chembl_id": null,
      "indications": [
        "Hypertension",
        "Diabetic nephropathy",
        "Heart failure"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "candesartan",
      "name": "candesartan",
      "target_protein_id": "AGTR1",
      "status": "approved",
      "drugbank_id": "DB00796",
      "chembl_id": null,
      "indications": [
        "Hypertension",
        "Heart failure"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "irbesartan",
      "name": "irbesartan",
      "target_protein_id": "AGTR1",
      "status": "approved",
      "drugbank_id": "DB00389",
      "chembl_id": null,
      "indications": [
        "Hypertension",
        "Diabetic nephropathy"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "olmesartan",
      "name": "olmesartan",
      "target_protein_id": "AGTR1",
      "status": "approved",
      "drugbank_id": "DB01265",
      "chembl_id": null,
      "indications": [
        "Hypertension"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "telmisartan",
      "name": "telmisartan",
      "target_protein_id": "AGTR1",
      "status": "approved",
      "drugbank_id": "DB00966",
      "chembl_id": null,
      "indications": [
        "Hypertension"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "valsartan",
      "name": "valsartan",
      "target_protein_id": "AGTR1",
      "status": "approved",
      "drugbank_id": "DB00177",
      "chembl_id": null,
      "indications": [
        "Hypertension",
        "Heart failure",
        "Post-myocardial infarction"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nitroglycerin",
      "name": "Nitroglycerin",
      "target_protein_id": "NOS3",
      "status": "approved",
      "drugbank_id": "DB00036",
      "chembl_id": null,
      "indications": [
        "Angina Pectoris",
        "Congestive Heart Failure",
        "Myocardial Infarction"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "albuterol",
      "name": "Albuterol",
      "target_protein_id": "ADRB2",
      "status": "approved",
      "drugbank_id": "DB00357",
      "chembl_id": null,
      "indications": [
        "Asthma",
        "Chronic Obstructive Pulmonary Disease (COPD)"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "formoterol",
      "name": "Formoterol",
      "target_protein_id": "ADRB2",
      "status": "approved",
      "drugbank_id": "DB00983",
      "chembl_id": null,
      "indications": [
        "Asthma",
        "Chronic Obstructive Pulmonary Disease (COPD)"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "salmeterol",
      "name": "Salmeterol",
      "target_protein_id": "ADRB2",
      "status": "approved",
      "drugbank_id": "DB00441",
      "chembl_id": null,
      "indications": [
        "Asthma",
        "Chronic Obstructive Pulmonary Disease (COPD)"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "terbutaline",
      "name": "Terbutaline",
      "target_protein_id": "ADRB2",
      "status": "approved",
      "drugbank_id": "DB00871",
      "chembl_id": null,
      "indications": [
        "Asthma",
        "Chronic Obstructive Pulmonary Disease (COPD)"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "metyrapone",
      "name": "Metyrapone",
      "target_protein_id": "CYP11B2",
      "status": "approved",
      "drugbank_id": "DB00904",
      "chembl_id": null,
      "indications": [
        "Cushing's syndrome"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "metformin",
      "name": "metformin",
      "target_protein_id": "INSR",
      "status": "approved",
      "drugbank_id": "DB00331",
      "chembl_id": null,
      "indications": [
        "Type 2 Diabetes Mellitus"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "pioglitazone",
      "name": "pioglitazone",
      "target_protein_id": "PPARG",
      "status": "approved",
      "drugbank_id": "DB00211",
      "chembl_id": null,
      "indications": [
        "Type 2 Diabetes Mellitus"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "rosiglitazone",
      "name": "rosiglitazone",
      "target_protein_id": "PPARG",
      "status": "approved",
      "drugbank_id": "DB00412",
      "chembl_id": null,
      "indications": [
        "Type 2 Diabetes Mellitus"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "corticotropin",
      "name": "Corticotropin",
      "target_protein_id": "POMC",
      "status": "approved",
      "drugbank_id": "DB00574",
      "chembl_id": null,
      "indications": [
        "Adrenocortical Insufficiency",
        "Multiple Sclerosis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "setmelanotide",
      "name": "setmelanotide",
      "target_protein_id": "MC4R",
      "status": "approved",
      "drugbank_id": "DB15003",
      "chembl_id": null,
      "indications": [
        "Obesity due to pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "fatostatin",
      "name": "Fatostatin",
      "target_protein_id": "SREBF1",
      "status": "approved",
      "drugbank_id": "DB12575",
      "chembl_id": null,
      "indications": [
        "Hyperlipidemia"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "tideglusib",
      "name": "Tideglusib",
      "target_protein_id": "MAPT",
      "status": "approved",
      "drugbank_id": "DB11573",
      "chembl_id": null,
      "indications": [
        "Alzheimer's Disease"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "verubecestat",
      "name": "Verubecestat",
      "target_protein_id": "BACE1",
      "status": "approved",
      "drugbank_id": "DB11660",
      "chembl_id": null,
      "indications": [
        "Alzheimer's Disease"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "levodopa",
      "name": "Levodopa",
      "target_protein_id": "SNCA",
      "status": "approved",
      "drugbank_id": "DB00171",
      "chembl_id": null,
      "indications": [
        "Parkinson's Disease"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "miglustat",
      "name": "Miglustat",
      "target_protein_id": "GBA",
      "status": "approved",
      "drugbank_id": "DB00684",
      "chembl_id": null,
      "indications": [
        "Gaucher's disease"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "eliglustat",
      "name": "Eliglustat",
      "target_protein_id": "GBA",
      "status": "approved",
      "drugbank_id": "DB09072",
      "chembl_id": null,
      "indications": [
        "Gaucher's disease"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "tetrabenazine",
      "name": "Tetrabenazine",
      "target_protein_id": "VMAT2",
      "status": "approved",
      "drugbank_id": "DB00656",
      "chembl_id": null,
      "indications": [
        "Huntington's Disease",
        "Tardive Dyskinesia"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "valbenazine",
      "name": "Valbenazine",
      "target_protein_id": "VMAT2",
      "status": "approved",
      "drugbank_id": "DB12267",
      "chembl_id": null,
      "indications": [
        "Tardive Dyskinesia"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "riluzole",
      "name": "Riluzole",
      "target_protein_id": "SOD1",
      "status": "approved",
      "drugbank_id": "DB00258",
      "chembl_id": null,
      "indications": [
        "Amyotrophic Lateral Sclerosis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "rolipram",
      "name": "Rolipram",
      "target_protein_id": "CREB1",
      "status": "approved",
      "drugbank_id": "DB01373",
      "chembl_id": null,
      "indications": [
        "Depression"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "emricasan",
      "name": "Emricasan",
      "target_protein_id": "CASP3",
      "status": "approved",
      "drugbank_id": "DB12148",
      "chembl_id": null,
      "indications": [
        "Nonalcoholic Steatohepatitis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "memantine",
      "name": "Memantine",
      "target_protein_id": "GRIN2B",
      "status": "approved",
      "drugbank_id": "DB00463",
      "chembl_id": null,
      "indications": [
        "Alzheimer's Disease"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "infliximab",
      "name": "infliximab",
      "target_protein_id": "TNF",
      "status": "approved",
      "drugbank_id": "DB00065",
      "chembl_id": null,
      "indications": [
        "Rheumatoid Arthritis",
        "Crohn's Disease",
        "Ulcerative Colitis",
        "Ankylosing Spondylitis",
        "Psoriatic Arthritis",
        "Plaque Psoriasis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "adalimumab",
      "name": "adalimumab",
      "target_protein_id": "TNF",
      "status": "approved",
      "drugbank_id": "DB00051",
      "chembl_id": null,
      "indications": [
        "Rheumatoid Arthritis",
        "Crohn's Disease",
        "Ulcerative Colitis",
        "Ankylosing Spondylitis",
        "Psoriatic Arthritis",
        "Plaque Psoriasis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "etanercept",
      "name": "etanercept",
      "target_protein_id": "TNF",
      "status": "approved",
      "drugbank_id": "DB00005",
      "chembl_id": null,
      "indications": [
        "Rheumatoid Arthritis",
        "Ankylosing Spondylitis",
        "Psoriatic Arthritis",
        "Plaque Psoriasis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "certolizumab_pegol",
      "name": "certolizumab pegol",
      "target_protein_id": "TNF",
      "status": "approved",
      "drugbank_id": "DB06073",
      "chembl_id": null,
      "indications": [
        "Rheumatoid Arthritis",
        "Crohn's Disease",
        "Ankylosing Spondylitis",
        "Psoriatic Arthritis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "golimumab",
      "name": "golimumab",
      "target_protein_id": "TNF",
      "status": "approved",
      "drugbank_id": "DB06265",
      "chembl_id": null,
      "indications": [
        "Rheumatoid Arthritis",
        "Ulcerative Colitis",
        "Ankylosing Spondylitis",
        "Psoriatic Arthritis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ipilimumab",
      "name": "ipilimumab",
      "target_protein_id": "CTLA4",
      "status": "approved",
      "drugbank_id": "DB05395",
      "chembl_id": null,
      "indications": [
        "Melanoma",
        "Renal Cell Carcinoma",
        "Microsatellite Instability-High or Mismatch Repair Deficient Solid Tumors"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "abatacept",
      "name": "abatacept",
      "target_protein_id": "HLA-DRB1",
      "status": "approved",
      "drugbank_id": "DB00095",
      "chembl_id": null,
      "indications": [
        "Rheumatoid Arthritis",
        "Juvenile Idiopathic Arthritis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "emapalumab",
      "name": "emapalumab",
      "target_protein_id": "IFNG",
      "status": "approved",
      "drugbank_id": "DB14941",
      "chembl_id": null,
      "indications": [
        "Primary Hemophagocytic Lymphohistiocytosis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "tofacitinib",
      "name": "tofacitinib",
      "target_protein_id": "STAT1",
      "status": "approved",
      "drugbank_id": "DB08895",
      "chembl_id": null,
      "indications": [
        "Rheumatoid arthritis",
        "Ulcerative colitis",
        "Psoriatic arthritis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "belimumab",
      "name": "belimumab",
      "target_protein_id": "BAFF",
      "status": "approved",
      "drugbank_id": "DB08916",
      "chembl_id": null,
      "indications": [
        "Systemic lupus erythematosus"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "secukinumab",
      "name": "secukinumab",
      "target_protein_id": "IL-17A",
      "status": "approved",
      "drugbank_id": "DB09035",
      "chembl_id": null,
      "indications": [
        "Plaque Psoriasis",
        "Psoriatic Arthritis",
        "Ankylosing Spondylitis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ixekizumab",
      "name": "ixekizumab",
      "target_protein_id": "IL-17A",
      "status": "approved",
      "drugbank_id": "DB11579",
      "chembl_id": null,
      "indications": [
        "Plaque Psoriasis",
        "Psoriatic Arthritis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "plerixafor",
      "name": "plerixafor",
      "target_protein_id": "CXCL12",
      "status": "approved",
      "drugbank_id": "DB06616",
      "chembl_id": null,
      "indications": [
        "Hematopoietic Stem Cell Mobilization"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "fresolimumab",
      "name": "fresolimumab",
      "target_protein_id": "TGFB1",
      "status": "approved",
      "drugbank_id": "DB11878",
      "chembl_id": null,
      "indications": [
        "Glioblastoma",
        "Melanoma"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "baricitinib",
      "name": "baricitinib",
      "target_protein_id": "STAT3",
      "status": "approved",
      "drugbank_id": "DB11817",
      "chembl_id": null,
      "indications": [
        "Rheumatoid arthritis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "muramyl_dipeptide",
      "name": "Muramyl Dipeptide",
      "target_protein_id": "NOD2",
      "status": "approved",
      "drugbank_id": "DB12048",
      "chembl_id": null,
      "indications": [
        "Crohn's Disease"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "guselkumab",
      "name": "guselkumab",
      "target_protein_id": "IL-23",
      "status": "approved",
      "drugbank_id": "DB11586",
      "chembl_id": null,
      "indications": [
        "Plaque Psoriasis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "risankizumab",
      "name": "risankizumab",
      "target_protein_id": "IL-23",
      "status": "approved",
      "drugbank_id": "DB14648",
      "chembl_id": null,
      "indications": [
        "Plaque Psoriasis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "tildrakizumab",
      "name": "tildrakizumab",
      "target_protein_id": "IL-23",
      "status": "approved",
      "drugbank_id": "DB11909",
      "chembl_id": null,
      "indications": [
        "Plaque Psoriasis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "bevacizumab",
      "name": "bevacizumab",
      "target_protein_id": "VEGF",
      "status": "approved",
      "drugbank_id": "DB00112",
      "chembl_id": null,
      "indications": [
        "Colorectal Cancer",
        "Non-Small Cell Lung Cancer",
        "Renal Cell Carcinoma",
        "Glioblastoma Multiforme",
        "Cervical Cancer",
        "Ovarian Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "aflibercept",
      "name": "aflibercept",
      "target_protein_id": "VEGF",
      "status": "approved",
      "drugbank_id": "DB08901",
      "chembl_id": null,
      "indications": [
        "Neovascular (Wet) Age-Related Macular Degeneration",
        "Diabetic Macular Edema",
        "Macular Edema Following Retinal Vein Occlusion"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ramucirumab",
      "name": "ramucirumab",
      "target_protein_id": "VEGF",
      "status": "approved",
      "drugbank_id": "DB09075",
      "chembl_id": null,
      "indications": [
        "Gastric Cancer",
        "Non-Small Cell Lung Cancer",
        "Colorectal Cancer",
        "Hepatocellular Carcinoma"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "axitinib",
      "name": "axitinib",
      "target_protein_id": "VEGF",
      "status": "approved",
      "drugbank_id": "DB08881",
      "chembl_id": null,
      "indications": [
        "Renal Cell Carcinoma"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "lenvatinib",
      "name": "lenvatinib",
      "target_protein_id": "VEGF",
      "status": "approved",
      "drugbank_id": "DB09079",
      "chembl_id": null,
      "indications": [
        "Thyroid Cancer",
        "Renal Cell Carcinoma",
        "Hepatocellular Carcinoma"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "cabozantinib",
      "name": "cabozantinib",
      "target_protein_id": "VEGF",
      "status": "approved",
      "drugbank_id": "DB08875",
      "chembl_id": null,
      "indications": [
        "Renal Cell Carcinoma",
        "Medullary Thyroid Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "regorafenib",
      "name": "regorafenib",
      "target_protein_id": "VEGF",
      "status": "approved",
      "drugbank_id": "DB08896",
      "chembl_id": null,
      "indications": [
        "Colorectal Cancer",
        "Gastrointestinal Stromal Tumors",
        "Hepatocellular Carcinoma"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "sorafenib",
      "name": "sorafenib",
      "target_protein_id": "VEGF",
      "status": "approved",
      "drugbank_id": "DB00398",
      "chembl_id": null,
      "indications": [
        "Renal Cell Carcinoma",
        "Hepatocellular Carcinoma",
        "Thyroid Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "zidovudine",
      "name": "Zidovudine",
      "target_protein_id": "HIV-1 Gag",
      "status": "approved",
      "drugbank_id": "DB00495",
      "chembl_id": null,
      "indications": [
        "HIV Infections"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "lamivudine",
      "name": "Lamivudine",
      "target_protein_id": "HIV-1 Gag",
      "status": "approved",
      "drugbank_id": "DB00709",
      "chembl_id": null,
      "indications": [
        "HIV Infections",
        "Hepatitis B"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "abacavir",
      "name": "Abacavir",
      "target_protein_id": "HIV-1 Gag",
      "status": "approved",
      "drugbank_id": "DB00118",
      "chembl_id": null,
      "indications": [
        "HIV Infections"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "emtricitabine",
      "name": "Emtricitabine",
      "target_protein_id": "HIV-1 Gag",
      "status": "approved",
      "drugbank_id": "DB00879",
      "chembl_id": null,
      "indications": [
        "HIV Infections",
        "Hepatitis B"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ibalizumab",
      "name": "Ibalizumab",
      "target_protein_id": "HIV-1 Env",
      "status": "approved",
      "drugbank_id": "DB11586",
      "chembl_id": null,
      "indications": [
        "HIV-1 infection",
        "HIV Infections"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "fostemsavir",
      "name": "Fostemsavir",
      "target_protein_id": "HIV-1 Env",
      "status": "approved",
      "drugbank_id": "DB15492",
      "chembl_id": null,
      "indications": [
        "HIV-1 infection"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "dolutegravir",
      "name": "Dolutegravir",
      "target_protein_id": "HIV-1 Tat",
      "status": "approved",
      "drugbank_id": "DB08930",
      "chembl_id": null,
      "indications": [
        "HIV Infections"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "bictegravir",
      "name": "Bictegravir",
      "target_protein_id": "HIV-1 Tat",
      "status": "approved",
      "drugbank_id": "DB13677",
      "chembl_id": null,
      "indications": [
        "HIV Infections"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "myrcludex_b",
      "name": "Myrcludex B",
      "target_protein_id": "NTCP",
      "status": "approved",
      "drugbank_id": "DB14326",
      "chembl_id": null,
      "indications": [
        "Chronic hepatitis B",
        "Chronic hepatitis D"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "doxycycline",
      "name": "Doxycycline",
      "target_protein_id": "MMP9",
      "status": "approved",
      "drugbank_id": "DB00254",
      "chembl_id": null,
      "indications": [
        "Bacterial Infections",
        "Malaria",
        "Acne"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "marimastat",
      "name": "Marimastat",
      "target_protein_id": "MMP9",
      "status": "approved",
      "drugbank_id": "DB00254",
      "chembl_id": null,
      "indications": [
        "Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "dupilumab",
      "name": "dupilumab",
      "target_protein_id": "IL4",
      "status": "approved",
      "drugbank_id": "DB11827",
      "chembl_id": null,
      "indications": [
        "Atopic Dermatitis",
        "Asthma",
        "Chronic Rhinosinusitis with Nasal Polyposis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "mepolizumab",
      "name": "mepolizumab",
      "target_protein_id": "IL5",
      "status": "approved",
      "drugbank_id": "DB11179",
      "chembl_id": null,
      "indications": [
        "Eosinophilic Asthma",
        "Eosinophilic Granulomatosis with Polyangiitis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "reslizumab",
      "name": "reslizumab",
      "target_protein_id": "IL5",
      "status": "approved",
      "drugbank_id": "DB11193",
      "chembl_id": null,
      "indications": [
        "Eosinophilic Asthma"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "tezepelumab",
      "name": "Tezepelumab",
      "target_protein_id": "TSLP",
      "status": "approved",
      "drugbank_id": "DB15568",
      "chembl_id": null,
      "indications": [
        "Asthma"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "pamrevlumab",
      "name": "pamrevlumab",
      "target_protein_id": "CTGF",
      "status": "approved",
      "drugbank_id": "DB15089",
      "chembl_id": null,
      "indications": [],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "batimastat",
      "name": "Batimastat",
      "target_protein_id": "MMP-7",
      "status": "approved",
      "drugbank_id": "DB00038",
      "chembl_id": null,
      "indications": [
        "Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "bindarit",
      "name": "Bindarit",
      "target_protein_id": "CCL2",
      "status": "approved",
      "drugbank_id": "DB11573",
      "chembl_id": null,
      "indications": [
        "Diabetic Nephropathy",
        "Diabetic Retinopathy"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "sunitinib",
      "name": "sunitinib",
      "target_protein_id": "PDGFRB",
      "status": "approved",
      "drugbank_id": "DB01268",
      "chembl_id": null,
      "indications": [
        "Renal Cell Carcinoma",
        "Gastrointestinal Stromal Tumors"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "fluoxetine",
      "name": "Fluoxetine",
      "target_protein_id": "5-HTT",
      "status": "approved",
      "drugbank_id": "DB00472",
      "chembl_id": null,
      "indications": [
        "Depression",
        "Obsessive-Compulsive Disorder",
        "Bulimia Nervosa",
        "Premenstrual Dysphoric Disorder"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "paroxetine",
      "name": "Paroxetine",
      "target_protein_id": "5-HTT",
      "status": "approved",
      "drugbank_id": "DB00715",
      "chembl_id": null,
      "indications": [
        "Depression",
        "Obsessive-Compulsive Disorder",
        "Panic Disorder",
        "Social Anxiety Disorder",
        "Generalized Anxiety Disorder",
        "Posttraumatic Stress Disorder"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "sertraline",
      "name": "Sertraline",
      "target_protein_id": "5-HTT",
      "status": "approved",
      "drugbank_id": "DB00280",
      "chembl_id": null,
      "indications": [
        "Depression",
        "Obsessive-Compulsive Disorder",
        "Panic Disorder",
        "Posttraumatic Stress Disorder",
        "Social Anxiety Disorder",
        "Premenstrual Dysphoric Disorder"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "escitalopram",
      "name": "Escitalopram",
      "target_protein_id": "5-HTT",
      "status": "approved",
      "drugbank_id": "DB00194",
      "chembl_id": null,
      "indications": [
        "Depression",
        "Generalized Anxiety Disorder"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "tacrolimus",
      "name": "Tacrolimus",
      "target_protein_id": "FKBP5",
      "status": "approved",
      "drugbank_id": "DB00864",
      "chembl_id": null,
      "indications": [
        "Organ transplant rejection",
        "Atopic dermatitis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "entacapone",
      "name": "Entacapone",
      "target_protein_id": "COMT",
      "status": "approved",
      "drugbank_id": "DB00494",
      "chembl_id": null,
      "indications": [
        "Parkinson's Disease"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "tolcapone",
      "name": "Tolcapone",
      "target_protein_id": "COMT",
      "status": "approved",
      "drugbank_id": "DB00494",
      "chembl_id": null,
      "indications": [
        "Parkinson's Disease"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "verapamil",
      "name": "Verapamil",
      "target_protein_id": "CACNA1C",
      "status": "approved",
      "drugbank_id": "DB00661",
      "chembl_id": null,
      "indications": [
        "Hypertension",
        "Angina Pectoris",
        "Supraventricular Tachycardia"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "sapropterin_dihydrochloride",
      "name": "sapropterin dihydrochloride",
      "target_protein_id": "PAH",
      "status": "approved",
      "drugbank_id": "DB06273",
      "chembl_id": null,
      "indications": [
        "Phenylketonuria"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "ivacaftor",
      "name": "Ivacaftor",
      "target_protein_id": "CFTR",
      "status": "approved",
      "drugbank_id": "DB08820",
      "chembl_id": null,
      "indications": [
        "Cystic Fibrosis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "lumacaftor/ivacaftor",
      "name": "Lumacaftor/Ivacaftor",
      "target_protein_id": "CFTR",
      "status": "approved",
      "drugbank_id": "DB11594",
      "chembl_id": null,
      "indications": [
        "Cystic Fibrosis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "tezacaftor/ivacaftor",
      "name": "Tezacaftor/Ivacaftor",
      "target_protein_id": "CFTR",
      "status": "approved",
      "drugbank_id": "DB13263",
      "chembl_id": null,
      "indications": [
        "Cystic Fibrosis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "elexacaftor/tezacaftor/ivacaftor",
      "name": "Elexacaftor/Tezacaftor/Ivacaftor",
      "target_protein_id": "CFTR",
      "status": "approved",
      "drugbank_id": "DB15365",
      "chembl_id": null,
      "indications": [
        "Cystic Fibrosis"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "alpha-1_proteinase_inhibitor",
      "name": "alpha-1 proteinase inhibitor",
      "target_protein_id": "SERPINA1",
      "status": "approved",
      "drugbank_id": "DB00033",
      "chembl_id": null,
      "indications": [
        "Emphysema",
        "Chronic Obstructive Pulmonary Disease (COPD)"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "reparixin",
      "name": "reparixin",
      "target_protein_id": "IL8",
      "status": "approved",
      "drugbank_id": "DB11871",
      "chembl_id": null,
      "indications": [
        "Reperfusion Injury"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "desipramine",
      "name": "Desipramine",
      "target_protein_id": "NE",
      "status": "approved",
      "drugbank_id": "DB00426",
      "chembl_id": null,
      "indications": [
        "Depression",
        "Neuropathic Pain"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "imipramine",
      "name": "Imipramine",
      "target_protein_id": "NE",
      "status": "approved",
      "drugbank_id": "DB00458",
      "chembl_id": null,
      "indications": [
        "Depression",
        "Enuresis",
        "Panic Disorder"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nortriptyline",
      "name": "Nortriptyline",
      "target_protein_id": "NE",
      "status": "approved",
      "drugbank_id": "DB00540",
      "chembl_id": null,
      "indications": [
        "Depression",
        "Neuropathic Pain"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "laronidase",
      "name": "Laronidase",
      "target_protein_id": "IDUA",
      "status": "approved",
      "drugbank_id": "DB00056",
      "chembl_id": null,
      "indications": [
        "Mucopolysaccharidosis I"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "idursulfase",
      "name": "idursulfase",
      "target_protein_id": "IDS",
      "status": "approved",
      "drugbank_id": "DB00507",
      "chembl_id": null,
      "indications": [
        "Mucopolysaccharidosis II (Hunter syndrome)"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "elosulfase_alfa",
      "name": "Elosulfase alfa",
      "target_protein_id": "GALNS",
      "status": "approved",
      "drugbank_id": "DB09065",
      "chembl_id": null,
      "indications": [
        "Mucopolysaccharidosis IVA (Morquio A syndrome)"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "vestronidase_alfa",
      "name": "Vestronidase Alfa",
      "target_protein_id": "NAGLU",
      "status": "approved",
      "drugbank_id": "DB13989",
      "chembl_id": null,
      "indications": [
        "Mucopolysaccharidosis IIIB (Sanfilippo syndrome type B)"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "palovarotene",
      "name": "Palovarotene",
      "target_protein_id": "ACVR1",
      "status": "approved",
      "drugbank_id": "DB11977",
      "chembl_id": null,
      "indications": [
        "Fibrodysplasia Ossificans Progressiva"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "etidronate",
      "name": "Etidronate",
      "target_protein_id": "ENPP1",
      "status": "approved",
      "drugbank_id": "DB00500",
      "chembl_id": null,
      "indications": [
        "Paget's disease of bone",
        "Heterotopic ossification"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "selumetinib",
      "name": "selumetinib",
      "target_protein_id": "NF1",
      "status": "approved",
      "drugbank_id": "DB11974",
      "chembl_id": null,
      "indications": [
        "Neurofibromatosis Type 1"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "trametinib",
      "name": "Trametinib",
      "target_protein_id": "MEK1/2",
      "status": "approved",
      "drugbank_id": "DB08912",
      "chembl_id": null,
      "indications": [
        "Melanoma",
        "Non-Small Cell Lung Cancer"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "cobimetinib",
      "name": "Cobimetinib",
      "target_protein_id": "MEK1/2",
      "status": "approved",
      "drugbank_id": "DB09075",
      "chembl_id": null,
      "indications": [
        "Melanoma"
      ],
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "binimetinib",
      "name": "Binimetinib",
      "target_protein_id": "MEK1/2",
      "status": "approved",
      "drugbank_id": "DB11827",
      "chembl_id": null,
      "indications": [
        "Melanoma"
      ],
      "sources": [
        "AI-generated"
      ]
    }
  ],
  "trials": [
    {
      "id": "nct03072043",
      "nct_id": "NCT03072043",
      "phase": "Phase I",
      "status": "Completed",
      "condition": "Solid Tumors",
      "target_protein_id": "TP53",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03072043",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03391050",
      "nct_id": "NCT03391050",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Acute Myeloid Leukemia",
      "target_protein_id": "TP53",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03391050",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03740712",
      "nct_id": "NCT03740712",
      "phase": "Phase III",
      "status": "Recruiting",
      "condition": "Myelodysplastic Syndromes",
      "target_protein_id": "TP53",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03740712",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02496663",
      "nct_id": "NCT02496663",
      "phase": "Phase III",
      "status": "Completed",
      "condition": "Non-Small Cell Lung Cancer",
      "target_protein_id": "EGFR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02496663",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03909334",
      "nct_id": "NCT03909334",
      "phase": "Phase II",
      "status": "Active, not recruiting",
      "condition": "Colorectal Cancer",
      "target_protein_id": "EGFR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03909334",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03654326",
      "nct_id": "NCT03654326",
      "phase": "Phase I",
      "status": "Recruiting",
      "condition": "Advanced Solid Tumors",
      "target_protein_id": "EGFR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03654326",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03600883",
      "nct_id": "NCT03600883",
      "phase": "Phase II",
      "status": "Active, not recruiting",
      "condition": "Non-Small Cell Lung Cancer",
      "target_protein_id": "KRAS",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03600883",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04685135",
      "nct_id": "NCT04685135",
      "phase": "Phase III",
      "status": "Recruiting",
      "condition": "Non-Small Cell Lung Cancer",
      "target_protein_id": "KRAS",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04685135",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04185883",
      "nct_id": "NCT04185883",
      "phase": "Phase I/II",
      "status": "Recruiting",
      "condition": "Advanced Solid Tumors",
      "target_protein_id": "KRAS",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04185883",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02576431",
      "nct_id": "NCT02576431",
      "phase": "Phase III",
      "status": "Completed",
      "condition": "Non-Small Cell Lung Cancer",
      "target_protein_id": "ALK",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02576431",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02501902",
      "nct_id": "NCT02501902",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Anaplastic Large Cell Lymphoma",
      "target_protein_id": "ALK",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02501902",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03052608",
      "nct_id": "NCT03052608",
      "phase": "Phase I",
      "status": "Completed",
      "condition": "Advanced Solid Tumors",
      "target_protein_id": "ALK",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03052608",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03541928",
      "nct_id": "NCT03541928",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Non-Small Cell Lung Cancer",
      "target_protein_id": "ERCC1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03541928",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03408601",
      "nct_id": "NCT03408601",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Ovarian Cancer",
      "target_protein_id": "ERCC1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03408601",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02326584",
      "nct_id": "NCT02326584",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Esophageal Cancer",
      "target_protein_id": "ERCC1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02326584",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03150576",
      "nct_id": "NCT03150576",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Breast Cancer",
      "target_protein_id": "BRCA1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03150576",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02282345",
      "nct_id": "NCT02282345",
      "phase": "Phase III",
      "status": "Active",
      "condition": "Ovarian Cancer",
      "target_protein_id": "BRCA1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02282345",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03330847",
      "nct_id": "NCT03330847",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Breast Cancer",
      "target_protein_id": "BRCA1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03330847",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03344965",
      "nct_id": "NCT03344965",
      "phase": "Phase III",
      "status": "Recruiting",
      "condition": "Metastatic Pancreatic Cancer",
      "target_protein_id": "BRCA2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03344965",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03742895",
      "nct_id": "NCT03742895",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Metastatic Castration-Resistant Prostate Cancer",
      "target_protein_id": "BRCA2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03742895",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03734029",
      "nct_id": "NCT03734029",
      "phase": "Phase III",
      "status": "Active, not recruiting",
      "condition": "Breast Cancer",
      "target_protein_id": "HER2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03734029",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04553770",
      "nct_id": "NCT04553770",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Breast Cancer",
      "target_protein_id": "HER2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04553770",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03975647",
      "nct_id": "NCT03975647",
      "phase": "Phase III",
      "status": "Recruiting",
      "condition": "Breast Cancer",
      "target_protein_id": "HER2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03975647",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03284957",
      "nct_id": "NCT03284957",
      "phase": "Phase III",
      "status": "Active, not recruiting",
      "condition": "Breast Cancer",
      "target_protein_id": "ESR1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03284957",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03778931",
      "nct_id": "NCT03778931",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Metastatic Breast Cancer",
      "target_protein_id": "ESR1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03778931",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04432454",
      "nct_id": "NCT04432454",
      "phase": "Phase III",
      "status": "Recruiting",
      "condition": "Metastatic Breast Cancer",
      "target_protein_id": "ESR1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04432454",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03006172",
      "nct_id": "NCT03006172",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Breast Cancer",
      "target_protein_id": "PIK3CA",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03006172",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02465060",
      "nct_id": "NCT02465060",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Colorectal Cancer",
      "target_protein_id": "PIK3CA",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02465060",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03842228",
      "nct_id": "NCT03842228",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Glioblastoma",
      "target_protein_id": "PTEN",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03842228",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03310541",
      "nct_id": "NCT03310541",
      "phase": "Phase I/II",
      "status": "Completed",
      "condition": "Advanced Solid Tumors",
      "target_protein_id": "PTEN",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03310541",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03678883",
      "nct_id": "NCT03678883",
      "phase": "Phase I",
      "status": "Recruiting",
      "condition": "Advanced Solid Tumors",
      "target_protein_id": "MYC",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03678883",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03678932",
      "nct_id": "NCT03678932",
      "phase": "Phase II",
      "status": "Active, not recruiting",
      "condition": "Relapsed/Refractory Diffuse Large B-Cell Lymphoma",
      "target_protein_id": "MYC",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03678932",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03678945",
      "nct_id": "NCT03678945",
      "phase": "Phase I",
      "status": "Recruiting",
      "condition": "Advanced Solid Tumors",
      "target_protein_id": "MYC",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03678945",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03065400",
      "nct_id": "NCT03065400",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Mantle Cell Lymphoma",
      "target_protein_id": "CCND1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03065400",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03470532",
      "nct_id": "NCT03470532",
      "phase": "Phase II",
      "status": "Active, not recruiting",
      "condition": "Breast Cancer",
      "target_protein_id": "CCND1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03470532",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03685032",
      "nct_id": "NCT03685032",
      "phase": "Phase I",
      "status": "Recruiting",
      "condition": "Advanced Solid Tumors",
      "target_protein_id": "CCND1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03685032",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03504683",
      "nct_id": "NCT03504683",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Familial Adenomatous Polyposis",
      "target_protein_id": "APC",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03504683",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02683395",
      "nct_id": "NCT02683395",
      "phase": "Phase I",
      "status": "Completed",
      "condition": "Colorectal Cancer",
      "target_protein_id": "APC",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02683395",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03379428",
      "nct_id": "NCT03379428",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Familial Adenomatous Polyposis",
      "target_protein_id": "APC",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03379428",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02097238",
      "nct_id": "NCT02097238",
      "phase": "Phase III",
      "status": "Completed",
      "condition": "Melanoma",
      "target_protein_id": "BRAF",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02097238",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03235517",
      "nct_id": "NCT03235517",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Non-Small Cell Lung Cancer",
      "target_protein_id": "BRAF",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03235517",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03235337",
      "nct_id": "NCT03235337",
      "phase": "Phase III",
      "status": "Active, not recruiting",
      "condition": "Melanoma",
      "target_protein_id": "BRAF",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03235337",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03009566",
      "nct_id": "NCT03009566",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Melanoma",
      "target_protein_id": "NRAS",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03009566",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02430714",
      "nct_id": "NCT02430714",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Acute Myeloid Leukemia",
      "target_protein_id": "NRAS",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02430714",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03352285",
      "nct_id": "NCT03352285",
      "phase": "Phase I",
      "status": "Recruiting",
      "condition": "Advanced Solid Tumors with NRAS Mutation",
      "target_protein_id": "NRAS",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03352285",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03607631",
      "nct_id": "NCT03607631",
      "phase": "Phase II",
      "status": "Active, not recruiting",
      "condition": "Colorectal Cancer",
      "target_protein_id": "MLH1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03607631",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03607747",
      "nct_id": "NCT03607747",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Endometrial Cancer",
      "target_protein_id": "MLH1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03607747",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03951350",
      "nct_id": "NCT03951350",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Colorectal Cancer",
      "target_protein_id": "MLH1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03951350",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03192345",
      "nct_id": "NCT03192345",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Metastatic Colorectal Cancer",
      "target_protein_id": "TGFBR2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03192345",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03470350",
      "nct_id": "NCT03470350",
      "phase": "Phase I",
      "status": "Active, not recruiting",
      "condition": "Advanced Solid Tumors",
      "target_protein_id": "TGFBR2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03470350",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04127800",
      "nct_id": "NCT04127800",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Metastatic Pancreatic Cancer",
      "target_protein_id": "TGFBR2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04127800",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03654833",
      "nct_id": "NCT03654833",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Pancreatic Cancer",
      "target_protein_id": "SMAD4",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03654833",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03511196",
      "nct_id": "NCT03511196",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Prostate Cancer",
      "target_protein_id": "PSA",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03511196",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03541655",
      "nct_id": "NCT03541655",
      "phase": "Phase III",
      "status": "Active, not recruiting",
      "condition": "Prostate Cancer",
      "target_protein_id": "PSA",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03541655",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03732820",
      "nct_id": "NCT03732820",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Prostate Cancer",
      "target_protein_id": "PSA",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03732820",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03075553",
      "nct_id": "NCT03075553",
      "phase": "Phase III",
      "status": "Active, not recruiting",
      "condition": "Metastatic Castration-Resistant Prostate Cancer",
      "target_protein_id": "AR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03075553",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03072238",
      "nct_id": "NCT03072238",
      "phase": "Phase III",
      "status": "Active, not recruiting",
      "condition": "Metastatic Castration-Sensitive Prostate Cancer",
      "target_protein_id": "AR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03072238",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04321096",
      "nct_id": "NCT04321096",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "COVID-19",
      "target_protein_id": "TMPRSS2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04321096",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04355052",
      "nct_id": "NCT04355052",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "COVID-19",
      "target_protein_id": "TMPRSS2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04355052",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04374019",
      "nct_id": "NCT04374019",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "COVID-19",
      "target_protein_id": "TMPRSS2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04374019",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03875378",
      "nct_id": "NCT03875378",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Prostate Cancer",
      "target_protein_id": "AMACR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03875378",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03009981",
      "nct_id": "NCT03009981",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Prostate Cancer",
      "target_protein_id": "AMACR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03009981",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04294277",
      "nct_id": "NCT04294277",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Prostate Cancer",
      "target_protein_id": "AMACR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04294277",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03906292",
      "nct_id": "NCT03906292",
      "phase": "Phase III",
      "status": "Recruiting",
      "condition": "Chronic Myelogenous Leukemia",
      "target_protein_id": "BCR-ABL1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03906292",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03106779",
      "nct_id": "NCT03106779",
      "phase": "Phase II",
      "status": "Active, not recruiting",
      "condition": "Chronic Myelogenous Leukemia",
      "target_protein_id": "BCR-ABL1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03106779",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02130557",
      "nct_id": "NCT02130557",
      "phase": "Phase III",
      "status": "Completed",
      "condition": "Chronic Myelogenous Leukemia",
      "target_protein_id": "BCR-ABL1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02130557",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02752035",
      "nct_id": "NCT02752035",
      "phase": "Phase III",
      "status": "Active, not recruiting",
      "condition": "Acute Myeloid Leukemia",
      "target_protein_id": "FLT3",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02752035",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03836209",
      "nct_id": "NCT03836209",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Acute Myeloid Leukemia",
      "target_protein_id": "FLT3",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03836209",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03258931",
      "nct_id": "NCT03258931",
      "phase": "Phase III",
      "status": "Recruiting",
      "condition": "Acute Myeloid Leukemia",
      "target_protein_id": "FLT3",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03258931",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03509294",
      "nct_id": "NCT03509294",
      "phase": "Phase I",
      "status": "Completed",
      "condition": "Acute Myeloid Leukemia",
      "target_protein_id": "NPM1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03509294",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03769532",
      "nct_id": "NCT03769532",
      "phase": "Phase I/II",
      "status": "Recruiting",
      "condition": "Acute Myeloid Leukemia",
      "target_protein_id": "NPM1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03769532",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04210336",
      "nct_id": "NCT04210336",
      "phase": "Phase I",
      "status": "Active, not recruiting",
      "condition": "Acute Myeloid Leukemia",
      "target_protein_id": "NPM1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04210336",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03825796",
      "nct_id": "NCT03825796",
      "phase": "Phase I",
      "status": "Completed",
      "condition": "Acute Myeloid Leukemia",
      "target_protein_id": "RUNX1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03825796",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04176250",
      "nct_id": "NCT04176250",
      "phase": "Phase I/II",
      "status": "Recruiting",
      "condition": "Myelodysplastic Syndrome",
      "target_protein_id": "RUNX1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04176250",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03399786",
      "nct_id": "NCT03399786",
      "phase": "Phase III",
      "status": "Completed",
      "condition": "Heterozygous Familial Hypercholesterolemia",
      "target_protein_id": "LDLR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03399786",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03711591",
      "nct_id": "NCT03711591",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Homozygous Familial Hypercholesterolemia",
      "target_protein_id": "LDLR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03711591",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03711576",
      "nct_id": "NCT03711576",
      "phase": "Phase III",
      "status": "Active, not recruiting",
      "condition": "Heterozygous Familial Hypercholesterolemia",
      "target_protein_id": "LDLR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03711576",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02207634",
      "nct_id": "NCT02207634",
      "phase": "Phase III",
      "status": "Completed",
      "condition": "Hypercholesterolemia",
      "target_protein_id": "PCSK9",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02207634",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02584504",
      "nct_id": "NCT02584504",
      "phase": "Phase III",
      "status": "Completed",
      "condition": "Hypercholesterolemia",
      "target_protein_id": "PCSK9",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02584504",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03001076",
      "nct_id": "NCT03001076",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Hypercholesterolemia",
      "target_protein_id": "HMGCR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03001076",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03491293",
      "nct_id": "NCT03491293",
      "phase": "Phase III",
      "status": "Completed",
      "condition": "Hypercholesterolemia",
      "target_protein_id": "HMGCR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03491293",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04271280",
      "nct_id": "NCT04271280",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Nonalcoholic Fatty Liver Disease",
      "target_protein_id": "HMGCR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04271280",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03882957",
      "nct_id": "NCT03882957",
      "phase": "Phase II",
      "status": "Active, not recruiting",
      "condition": "Alzheimer's Disease",
      "target_protein_id": "APOE",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03882957",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04486600",
      "nct_id": "NCT04486600",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Alzheimer's Disease",
      "target_protein_id": "APOE",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04486600",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03491150",
      "nct_id": "NCT03491150",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Alzheimer's Disease",
      "target_protein_id": "APOE",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03491150",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03520557",
      "nct_id": "NCT03520557",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Alzheimer's Disease",
      "target_protein_id": "ABCA1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03520557",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03227862",
      "nct_id": "NCT03227862",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Atherosclerosis",
      "target_protein_id": "ABCA1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03227862",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02581085",
      "nct_id": "NCT02581085",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Familial Hypercholesterolemia",
      "target_protein_id": "ABCA1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02581085",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03366050",
      "nct_id": "NCT03366050",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Major Depressive Disorder",
      "target_protein_id": "BDNF",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03366050",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03191526",
      "nct_id": "NCT03191526",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Alzheimer's Disease",
      "target_protein_id": "BDNF",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03191526",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03368573",
      "nct_id": "NCT03368573",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Amyotrophic Lateral Sclerosis",
      "target_protein_id": "BDNF",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03368573",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03510508",
      "nct_id": "NCT03510508",
      "phase": "Phase III",
      "status": "Completed",
      "condition": "Rheumatoid Arthritis",
      "target_protein_id": "IL-6",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03510508",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03926143",
      "nct_id": "NCT03926143",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "COVID-19",
      "target_protein_id": "IL-6",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03926143",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03926130",
      "nct_id": "NCT03926130",
      "phase": "Phase III",
      "status": "Recruiting",
      "condition": "Systemic Sclerosis",
      "target_protein_id": "IL-6",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03926130",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03889327",
      "nct_id": "NCT03889327",
      "phase": "Phase III",
      "status": "Active, not recruiting",
      "condition": "Hypertension",
      "target_protein_id": "ACE",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03889327",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03198793",
      "nct_id": "NCT03198793",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Diabetic Kidney Disease",
      "target_protein_id": "ACE",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03198793",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03521934",
      "nct_id": "NCT03521934",
      "phase": "Phase III",
      "status": "Recruiting",
      "condition": "Heart Failure with Preserved Ejection Fraction",
      "target_protein_id": "ACE",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03521934",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03373785",
      "nct_id": "NCT03373785",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Hypertension",
      "target_protein_id": "AGTR1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03373785",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03914390",
      "nct_id": "NCT03914390",
      "phase": "Phase III",
      "status": "Recruiting",
      "condition": "Diabetic Nephropathy",
      "target_protein_id": "AGTR1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03914390",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04304924",
      "nct_id": "NCT04304924",
      "phase": "Phase II",
      "status": "Active, not recruiting",
      "condition": "Pulmonary Arterial Hypertension",
      "target_protein_id": "AGTR1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04304924",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03264338",
      "nct_id": "NCT03264338",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Pulmonary Arterial Hypertension",
      "target_protein_id": "NOS3",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03264338",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03443518",
      "nct_id": "NCT03443518",
      "phase": "Phase III",
      "status": "Active, not recruiting",
      "condition": "Sickle Cell Disease",
      "target_protein_id": "NOS3",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03443518",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03366350",
      "nct_id": "NCT03366350",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Chronic Obstructive Pulmonary Disease (COPD)",
      "target_protein_id": "ADRB2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03366350",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03955913",
      "nct_id": "NCT03955913",
      "phase": "Phase III",
      "status": "Recruiting",
      "condition": "Asthma",
      "target_protein_id": "ADRB2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03955913",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04395638",
      "nct_id": "NCT04395638",
      "phase": "Phase II",
      "status": "Active, not recruiting",
      "condition": "Chronic Heart Failure",
      "target_protein_id": "ADRB2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04395638",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03883568",
      "nct_id": "NCT03883568",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Primary Aldosteronism",
      "target_protein_id": "CYP11B2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03883568",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03879629",
      "nct_id": "NCT03879629",
      "phase": "Phase II",
      "status": "Active, not recruiting",
      "condition": "Primary Aldosteronism",
      "target_protein_id": "CYP11B2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03879629",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03879642",
      "nct_id": "NCT03879642",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Primary Aldosteronism",
      "target_protein_id": "CYP11B2",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03879642",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03865927",
      "nct_id": "NCT03865927",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Type 2 Diabetes Mellitus",
      "target_protein_id": "INSR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03865927",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03736785",
      "nct_id": "NCT03736785",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Insulin Resistance",
      "target_protein_id": "INSR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03736785",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02524782",
      "nct_id": "NCT02524782",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Polycystic Ovary Syndrome",
      "target_protein_id": "INSR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02524782",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03776630",
      "nct_id": "NCT03776630",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Type 2 Diabetes Mellitus",
      "target_protein_id": "GLUT4",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03776630",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03366351",
      "nct_id": "NCT03366351",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Obesity",
      "target_protein_id": "GLUT4",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03366351",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04127943",
      "nct_id": "NCT04127943",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Prediabetes",
      "target_protein_id": "GLUT4",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04127943",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03965494",
      "nct_id": "NCT03965494",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Metastatic Breast Cancer",
      "target_protein_id": "IRS1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03965494",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03690193",
      "nct_id": "NCT03690193",
      "phase": "Phase I",
      "status": "Active, not recruiting",
      "condition": "Advanced Solid Tumors",
      "target_protein_id": "IRS1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03690193",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03396537",
      "nct_id": "NCT03396537",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Type 2 Diabetes Mellitus",
      "target_protein_id": "PPARG",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03396537",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct02653209",
      "nct_id": "NCT02653209",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Non-alcoholic Fatty Liver Disease",
      "target_protein_id": "PPARG",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT02653209",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03746080",
      "nct_id": "NCT03746080",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Obesity",
      "target_protein_id": "ADIPOQ",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03746080",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04057794",
      "nct_id": "NCT04057794",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Type 2 Diabetes Mellitus",
      "target_protein_id": "ADIPOQ",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04057794",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04338360",
      "nct_id": "NCT04338360",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Nonalcoholic Fatty Liver Disease",
      "target_protein_id": "ADIPOQ",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04338360",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03283696",
      "nct_id": "NCT03283696",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Obesity",
      "target_protein_id": "LEP",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03283696",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03287960",
      "nct_id": "NCT03287960",
      "phase": "Phase III",
      "status": "Active, not recruiting",
      "condition": "Obesity due to Bardet-Biedl Syndrome or Alstr\u00f6m Syndrome",
      "target_protein_id": "LEP",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03287960",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04126317",
      "nct_id": "NCT04126317",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Obesity, Hyperphagia",
      "target_protein_id": "LEP",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04126317",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04163393",
      "nct_id": "NCT04163393",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Obesity",
      "target_protein_id": "LEPR",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04163393",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03845166",
      "nct_id": "NCT03845166",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Obesity",
      "target_protein_id": "POMC",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03845166",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03845179",
      "nct_id": "NCT03845179",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Hypothalamic Obesity",
      "target_protein_id": "POMC",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03845179",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04165005",
      "nct_id": "NCT04165005",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Prader-Willi Syndrome",
      "target_protein_id": "POMC",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04165005",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03480593",
      "nct_id": "NCT03480593",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Obesity",
      "target_protein_id": "FTO",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03480593",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03480606",
      "nct_id": "NCT03480606",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Obesity",
      "target_protein_id": "FTO",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03480606",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04551885",
      "nct_id": "NCT04551885",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Obesity",
      "target_protein_id": "FTO",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04551885",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct03745638",
      "nct_id": "NCT03745638",
      "phase": "Phase II",
      "status": "Completed",
      "condition": "Non-alcoholic Fatty Liver Disease",
      "target_protein_id": "SREBF1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT03745638",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04620330",
      "nct_id": "NCT04620330",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Non-alcoholic Steatohepatitis",
      "target_protein_id": "SREBF1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04620330",
      "sources": [
        "AI-generated"
      ]
    },
    {
      "id": "nct04720132",
      "nct_id": "NCT04720132",
      "phase": "Phase II",
      "status": "Recruiting",
      "condition": "Non-alcoholic Fatty Liver Disease",
      "target_protein_id": "SREBF1",
      "start_date": null,
      "link": "https://clinicaltrials.gov/study/NCT04720132",
      "sources": [
        "AI-generated"
      ]
    }
  ]
}